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ABSTRACT
The emerging field of micro total analysis system (µTAS) powered by microfluidics is expected
to revolutionize miniaturization and automation for point-of-care-testing systems which require
quick, efficient and reproducible results. In the present study, a PDMS based µTAS has been
developed for rapid, multi-purpose, impedance based detection of biomolecules. The major
components of the µTAS include a micropump, micromixer, magnetic separator and
interdigitated electrodes for impedance detection. Three designs of pneumatically actuated
PDMS based micropumps were fabricated and tested. Based on the performance test results, one
of the micropumps was selected for integration. The experimental results of the micropump
performance were confirmed by a 2D COMSOL simulation combined with an equivalent circuit
analysis of the micropump.

Three designs of pneumatically actuated PDMS based active

micromixers were fabricated and tested. The micromixer testing involved determination of
mixing efficiency based on the streptavidin-biotin conjugation reaction between biotin
comjugated fluorescent microbeads and streptavidin conjugated paramagnetic microbeads,
followed by fluorescence measurements. Based on the performance test results, one of the
micromixers was selected for integration.

The selected micropump and micromixer were

integrated into a single microfluidic system. The testing of the magnetic separation scheme
involved comparison of three permanent magnets and three electromagnets of different sizes and
magnetic strengths, for capturing magnetic microbeads at various flow rates. Based on the test
results, one of the permanent magnets was selected. The interdigitated electrodes were fabricated
on a glass substrate with gold as the electrode material. The selected micropumps, micromixer
and interdigitated electrodes were integrated to achieve a fully integrated microfluidic system.
The fully integrated microfluidic system was first applied towards biotin conjugated fluorescent

microbeads detection based on streptavidin-biotin conjugation reaction which is followed by
impedance spectrum measurements. The lower detection limit for biotin conjugated fluorescent
microbeads was experimentally determined to be 1.9 x 106 microbeads. The fully integrated
microfluidic system was then applied towards immuno microbead based insulin detection. The
lower detection limit for insulin was determined to be 10-5M. The total detection time was 20
min. An equivalent circuit analysis was performed to explain the impedance spectrum results.
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1. INTRODUCTION
1.1

Microelectromechanical Systems (MEMS)

MEMS refers to devices that have a characteristic length scale between 1 µm and 1 mm. MEMS
devices usually combine electrical and mechanical components and are fabricated using
integrated circuit batch-processing technologies. These devices have the ability to sense, control
and actuate on the micro scale. Most of the MEMS fabrication methods were developed in the
1970s and 1980s by the silicon microprocessor industry. In 1975, the first analytical MEMS
device fabricated on silicon, a gas chromatographic analyzer was reported [1]. This gas
chromatograph was able to separate a simple mixture of compounds in a few seconds. Most of
the research work during the period from 1975 - 1989 was focused on the microfabrication of
silicon based components such as micropumps [2], microvalves [3], and Ion-Sensitive FieldEffect (ISFET) chemical sensors [4]. Some of the early MEMS components that were used in
commercial products and applications include accelerometers used to control airbag deployment
in vehicles, pressure sensors for medical applications, and inkjet printer heads. In 1990, the
silicon-based analyzers re-emerged with a miniaturized open-tubular liquid chromatograph on a
silicon wafer [5]. In 1990s, the MEMS industry diversified and devices were fabricated for
chemical, biological, and biomedical applications which led to the creation of a new discipline
called microfluidics. Microfluidic devices include micrometer sized channels, chambers, filters
and other components to manipulate sub-μL to μL volumes of samples and reagents. Fluid flows
in micro devices are significantly different from their macroscopic counterparts. The surface to
volume ratio for a machine with a characteristic length of 1 m is 1 m-1, while that for MEMS
devices with a size of 1 μm is 106 m-1. The million fold increase in the surface to volume ratio
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substantially affects the transport of mass, momentum and energy through the surface. The
MEMS component market is expected to reach $20B in 2016 [6].
1.2

Microfabrication

The two most common methods for production of MEMS devices are surface micromachining
and bulk micromachining. Surface micromachining is an additive process. It consists of a series
of deposition, patterning and etching of thin films with thickness typically in the range of 1-100
μm. One of the crucial steps in surface micromachining is the selective removal of the
underlying film (sacrificial layer) without damaging the overlying films (structural layer). Many
commercial MEMS products such as airbag sensors apply this fabrication technique. Bulk
micromachining is a subtractive fabrication method which involves patterning and etching of the
substrate materials such as silicon, quartz, SiC, GaAs, and glass. The etching can be carried out
using orientation dependent (anisotropic) or orientation independent (isotropic) wet etchants. If
the process requires a dry environment, deep reactive ion etching (DRIE), a Bosch process
invented and patented by Robert Bosch GmbH in Reutlingen, Germany, can be used to pattern
silicon based materials. DRIE is a two-step process consisting of an etching and a passivation
cycle. In the etching cycle, silicon is removed using SF6 and in the passivation cycle, C4F8 is used
to produce a very thin layer of fluorocarbon polymer to passivate the side walls. In the following
etch cycle the polymer film at the bottom of the trench is removed by ion bombardment, while
the side walls are protected by the polymer film. The two step process is repeated until the
desired depth is attained. With DRIE, microfeatures with high aspect ratios can be fabricated.
Bulk and surface micromachining are limited to high stiffness semiconductor materials with
Young’s modulus ~ 100 GPa [7]. The stiffness of the material is important as it affects the forces
generated by the micro actuators. Furthermore, for active devices requiring multiple layers of
2

materials, adhesion between layers is of great concern. For bulk micromachining, complicated
wafer bonding techniques are required to produce multilayer structures. For surface
micromachining, thermal stress between layers limits the total thickness to ~ 20 μm [8]. Bulk and
surface micromachining require clean room environment and fine control of process conditions
in order to realize devices with good yields.
Micromolding is suitable for large scale production of polymeric devices. The most common
techniques in micromolding are injection molding and compression molding. In injection
molding, metal mold inserts are used as a replica master and the molding process is carried out at
temperatures above the glass transition temperatures of amorphous thermoplastics such as
polymethylmethacrylate (PMMA) and polyamide. Compression molding or hot embossing is a
technique where the desired structure is pressed under vacuum into a semi-finished polymer
material at an elevated temperature above the glass transition temperature. LIGA (lithographie
galvanoformung abformtechnik) is a fabrication technique involving X-Ray lithography,
electroforming, and a micromolding process [9]. Metal or plastic microstructures with straight
sidewall and high aspect ratio (over 100:1) can be fabricated using LIGA.
Soft lithography is gaining popularity as an alternative to photolithography and is useful for
prototyping of devices useful for applications in life sciences research. In soft lithography, a
topologically patterned stamp (or mold) is used to transfer a pattern to a substrate [10]. There are
two types of soft lithography [10]: 1) the replication of a pattern defined in a soft (elastomeric)
stamp into organic material or onto the surface of metals, ceramics etc. 2) replication of a pattern
defined in a hard stamp into a thin layer of soft organic molecules (e.g. thermoplastic polymers).
The second type of soft lithography has been widely used in recent times to fabricate
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microfluidic devices with SU-8 structures on silicon wafer as a mold and polydimethylsiloxane
(PDMS) as the soft structural material for the device.
Soft lithography provides researchers with rapid prototyping from design to prototype in 24-48
hours using equipment found in most scientific laboratories. The tolerant process conditions of
soft lithography permits the devices to be produced in ambient laboratory conditions without a
need for clean room environment. The capabilities of soft lithography are compatible with
requirement of devices in biology and biochemistry. It is easier to produce multi layered devices
with soft lithography when compared to conventional micromachining. Furthermore, since the
multilayer devices produced by soft lithography are monolithic, thermal stresses are avoided and
interlayer adhesion failures are reduced.
1.2.1 Fabrication Materials for Microfluidic Devices
Microfluidic devices have been fabricated from various materials which include silicon, glass,
ceramic, hard plastics and elastomers. In recent years, ever since Whitesides’ group introduced
the soft-lithography technique [11], PDMS casting on SU-8 mold has been extensively used in
various microﬂuidic research activities. There has been an increasing interest in rapidly
prototyping microfluidic systems in PDMS as an alternative to glass and silicon based systems.
PDMS micro-molding techniques have been used to fabricate microfluidic systems by many
groups [12-15]. PDMS is a low-cost material when compared to traditional micro-fabrication
materials, such as silicon and glass. A major advantage of PDMS is that once a master mold is
fabricated, multiple devices can be rapidly cast without the need for a clean room environment.
PDMS processes are simple and rapid when compared to traditional etching and bonding
approaches. The patterned PDMS layers can be stacked to make multilayered device structures.

4

PDMS rapid prototyping enables device design modifications and optimization to be completed
in a shorter time with minimum cost. PDMS is self-releasing and leaves very little residue on a
mold, thus allowing the mold to be reused for a long time.
Some of the other advantages of PDMS include:
1. Excellent optical properties (with transparency down to 280 nm) for optical detection
schemes.
2. It can be thermally cured at low temperatures (at room temperature in 24 hours and at
80ºC in 2 hours).
3. Features on the micron scale can be reproduced with high resolution.
4. Non-toxic and biocompatible.
5. Its surface properties can be easily modified to be hydrophobic or hydrophilic by wellestablished surface treatment protocols.
6. Its elastic properties can be easily altered by changing the mixing ratios of the base and
curing agent of the pre-polymer.
SYLGARD 184 Silicone Elastomer Kit (Dow Corning, Midland, MI) is widely used to prepare
PDMS. The SYLGARD 184 PDMS kit consists of a curing agent and prepolymer which can be
mixed in a 1:10 ratio and thermally cured to obtain PDMS. Traditionally, thick (> 100 μm) and
high aspect ratio microstructures have been fabricated using LIGA [16], microstereolithography
[17] and DRIE [18] processes. These techniques require complex and expensive equipment that
are not readily accessible to small scale laboratory facilities. The application of SU-8
(MicroChem Corp., Newton, MA) to fabricate thick microstructures for MEMS applications has
attracted lot of interest [19] in the recent years. SU-8 is a high contrast, negative, epoxy-based
line of near-ultraviolet (UV) radiation-sensitive photoresists with suitable chemical and
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mechanical properties that can be used to fabricate high aspect ratio microstructures with nearvertical side walls in a single photolithographic step [19]. A developed SU-8 structures is
thermally (up to 200 °C) and chemically stable,

making them well suited for fabricating

permanent structures such as pixel walls, fluidic channels, nozzles, micro arrays and spacers.
1.3

Miniaturization of Diagnostic Assays

A wide variety of classical, macroscopic liquid handling systems for performing analytical and
diagnostic assays have been in use for many decades. Miniaturization of the macroscopic liquid
handling system has become a popular trend in the last few decades and has led to a new class of
microanalyzers. The common feature of all these devices is the miniaturization of an analytical
process or part of the analytical process into a device built on a small substrate of glass, plastic or
silicon.
There are several compelling reasons for the miniaturization of analyzers. The scaling effects due
to decreased length scales allow for new applications that are not achievable in macroscopic
liquid handling systems. Miniaturization makes the analytical processes cost effective by
reducing the volume of reagents used per assay (in the order of nano to pico liter) when
compared to the traditional analysis. In case of drug discovery applications, where there is a
limited amount of drug compound to be tested, a reduction in the volume of the reagents, allows
more tests to be performed on that drug compound. The reduction in footprint of each individual
test enables a higher degree of parallelization within a small space. A key example is parallel
reactions in hundreds of thousands of individual wells with picoliter volumes and minimum
reagent consumption for genome sequencing [20]. The chemical reaction rate is high and the
response time of the device is fast due to the small scale of the devices and smaller volumes of
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the samples. Due to decreasing length scales, surface phenomenon such as capillary forces and
surface charges in miniaturized devices becomes dominant. This permits purely passive liquid
actuation based on capillary forces in the lateral flow assays also known as capillary test strips.
Another outcome is the onset of a laminar flow at low Reynolds number in small channels. This
enables the creation of well-defined and stable liquid-liquid interfaces. The use of multiple
laminar streams in a microfluidic channel to deliver membrane permeable molecules to selected
subcellular microdomains has been reported [21]. Another important advantage of
miniaturization is the ability to integrate all the steps of a multi-step analytical process on to a
single device. It is possible to design a microsystem which can be used to perform different tasks
like sample addition, processing and analysis, all on a microchip that is 2 cm × 2 cm or smaller
[22]. This concept is very similar to the integrated electronic circuits, where millions of
individual components are integrated into a single chip. Some of the other helpful properties of
small assay volumes are fast thermal reaction and low power consumption for liquid
manipulation and thermal control [23]. This can speed up assays such as PCR that require a
thermocycling step. However, miniaturization has some disadvantages. The small size of the
microchip can make their handling difficult. This can only be overcome by packaging the
microchip into a larger holder or by mounting the microchip onto a platform. A drastic reduction
in the sample size can sometimes make the sample a bad representative of the specimen such as
non-homogenous biological specimens that contain a diversity of constituents like cells, proteins,
etc. This problem can be overcome by developing flow-through sampling in which large
volumes of the sample are transported through a low volume microanalyzer. Another problem
associated with sample volume reduction is the detection limit. If the concentration of the analyte
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is low in the specimen, a volume reduction can decrease the quantity of the analyte detectable by
the microanalyzer.
1.4

Microfluidic System Designs

A microfluidic system provides a set of fluidic unit operations, which provide a generic and
consistent way for miniaturization, integration, automation and parallelization of (bio-) chemical
processes [23]. Microfluidic systems can be broadly classified according to the main liquid
propulsion principle as shown in Figure 1.1.

Figure 1.1 Microfluidic systems classified according to their main liquid propulsion principle
1.4.1 Capillary
Lateral flow (LF) tests are commonly known as test strips where the sample liquids are driven by
capillary forces. The liquid flow is controlled by the wettability and feature size of the
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microstructured substrate. All the required chemicals are pre-stored within the test strip. The test
results are optical signals and are usually implemented as a color change in the detection area
that is visible to the naked eye.
1.4.2 Pressure Driven
In linear actuated devices (LAD), liquid movement is controlled by mechanical displacements of
a plunger. Liquid flow is usually restricted to a single direction without any branches or alternate
flow pathways. In these devices, the calibration liquids and buffers are usually pre-stored in
pouches. A pressure driven laminar flow (PDLF) system is characterized by a liquid transport
due to pressure gradients. Typically, this creates stable laminar flow profiles within the
microchannels. There are a wide range of external and internal pressure sources such as syringe,
pumps or micropumps, gas expansion principles, and pneumatic displacement of a flexible
membrane that can be used to implement a PDLF. A pressure driven microfluidic system has
been implemented in the present study.
The samples and reagents are usually injected into the chip inlets, either in a batch or a
continuous mode. PDLF offers predictable velocity profiles and controllable diffusion mixing.
Microfluidic large scale integration (MLSI) describes a microfluidic channel circuitry with chipintegrated microvalves based on flexible membranes between a liquid-guiding layer and a
pneumatic control-channel layer. The microvalves open and close according to the pneumatic
pressure applied to the control-channels. Complex units such as micropumps, mixers, and
multiplexers can be designed by combining several microvalves on one single chip. The MLSI
platform developed in 1993 [24] when combined with soft lithography techniques enabled the
monolithic fabrication of all necessary fluidic components within one single elastomer material
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such as PDMS. Segmented flow microfluidics (SFM) transport small liquid plugs and/or droplets
immersed in a secondary immiscible continuous phase (gas or liquid) within closed microfluidic
channels [23]. The plugs/droplets are typically in the picoliter to microliter volume range and
can be transported by pressure gradients generated by external pressure sources. The
plugs/droplets can be merged, split, sorted, and processed.
1.4.3 Other Systems
In centrifugal microfluidics (CM), all processes are controlled by the frequency protocol of a
rotating microstructured substrate [23]. The forces involved in the liquid transport include
centrifugal force, Euler force, Coriolis force and capillary force. All the assays are implemented
as a sequence of liquid operations in a radially inward to outward direction. In electrokinetic
(EK) system, microfluidic operations are performed by electric fields acting on electric charges
or electric field gradients acting on electric dipoles [23].

Several EK effects such as

electroosmosis (EO), electrophoresis (EP), dielectrophoresis (DEP) and polarization can be
superimposed on each other. EO can be used to transport bulk liquid, while other effects can be
used to separate different types of molecules within the bulk liquid. Electrowetting (EW) systems
use droplets on a hydrophobic surface that contain one- or two- dimensional array of individually
addressable electrodes. The droplets can be generated, transported, split, merged and processed
by changing the voltage between neighboring electrodes. The surface acoustic wave (SAW)
system uses droplets residing on a hydrophobic solid support in a gaseous environment (air) and
the microfluidic unit operations are mainly controlled by acoustic shock waves travelling on the
surface of the solid support [23]. The shock waves are generated by a piezoelectric transducer
(PZT) chip consisting of interdigitated electrodes (IDE) placed on top of a piezoelectric layer.
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1.5

Biosensing

Microorganisms such as bacteria and virus are an integral part of life on earth. Some of these
microorganisms are pathogenic in nature and can cause disastrous effects on human health. The
detection of pathogenic bacteria and viruses is a key to the prevention and identification of many
health problems. Similarly, the ability to detect physiologically significant biomolecules in the
body with high sensitivity and specificity offers a powerful prospect in early diagnosis and
treatment of diseases. Early detection and diagnosis can significantly reduce the cost of patient
care associated with advanced stages of many diseases. Figure 1.2 [25] shows that the food
industry [26-27] water and environment quality control [28-29] and clinical diagnosis [30]
constitute over two thirds of all research activities. The food industry dominates the need for
pathogen detection. There are tough legislations in the food industry, where a failure to detect a
contamination can lead to widespread public health damages. More than 200 known diseases are
transmitted through food [31] and the symptoms of foodborne illnesses range from mild
gastroenteritis to life-threatening neurologic, hepatic, and renal syndromes. It has been reported
[32] that foodborne diseases cause approximately 76 million illnesses, 325,000 hospitalizations,
and 5,000 deaths in the United States each year. The USDA estimates that $2.9 - $6.7 billion is
lost annually due to medical costs and loss in productivity caused by major foodborne pathogens
[33].
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Figure 1.2 Distribution, by industry of application, of the relative number of works appeared in
the literature on detection of pathogenic bacteria
The cost for patient care at advanced stages has been estimated to be $75 billion [34] and $90
billion [35] for cancer and diabetes, respectively. At present, cancer detection can be done by
monitoring the concentration of certain antigens present in the bloodstream or other bodily
fluids, or through tissue examinations. Diabetes is monitored by determining the glucose
concentrations in the blood over time. But despite their widespread clinical use, these diagnostic
techniques have a number of limitations. In order to diagnose and monitor various diseases in a
patient, it is a common practice to examine blood/urine samples and perform various
biochemical tests on the samples. Most clinical diagnostic applications have focused on the
detection of biomolecules as early indicators of diseases but can also include monitoring of
regular metabolic parameters such as glucose and lactate [36]. These tests require specific
analytical techniques, as well as skilled personnel to collect the desired samples from the patient
and perform the tests.
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1.6

Pathogens and Biomolecules

Biosensors can detect pathogens such as bacteria, viruses or a range of biomolecules such as
proteins, enzymes, DNA and RNA for clinical diagnostics. Foodborne illnesses can be caused by
pathogens such as bacteria, viruses, parasites, toxins and prions [32]. The four major foodborne
bacteria are Salmonella, Listeria monocytogenes, Campylobacter and Escherichia coli (E. coli)
O157:H7. Viral infections can present generic symptoms and can be difficult to diagnose. A
biosensor would allow a physician to determine the specific virus quickly and prescribe
appropriate treatment. Viruses are capable of spreading rapidly by natural means and their ability
to mutate quickly makes their detection a challenging task. In recent times, the emergence of
avian influenza (AI) with pandemic potential has made the rapid screening of AI virus strains
crucial in controlling worldwide outbreaks. Some of the other viruses of interest include dengue
virus [37] rabies virus [38], human immunodeficiency virus (HIV) [39] and Adenovirus [40].
The rapid and quantitative detection of biomolecules such as protein biomarkers and nucleic
acids is important for both clinical diagnostics and drug discovery applications. Early detection is
particularly important in cases such as cancer, because the detection of the early stages of a
disease can enable a greater probability of a successful treatment.
1.6.1 Bacteria and Viruses
Among the various types of bacteria, the most economically significant [41] infections are
caused by E. coli O157:H7. Although most strains are harmless and some even live in the
intestines of healthy humans and animals, the O157:H7 strain produces a potent toxin and can
cause severe illness. Typical symptoms include abdominal cramping, diarrhea and bloody stools.
Occasionally this infection results in kidney failure. There have been many instances of meat
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recalls in the past. For example, in 2003, Howard Beef Processors in Minnesota voluntarily
recalled approximately 194,700 pounds of frozen ground beef products. Recalls of this kind can
be avoided if the bacteria are detected in advance before the meat reaches the market.
Among the various types of viruses, avian influenza (AI) virus has raised concerns about a
potential pandemic. AI viruses are classified into sub-types based on antigenic differences of the
surface glycoproteins, namely Hemagglutinin (HA) and neuraminidase (NA). To date, sixteen
HA (H1 through H16) and nine NA (N1 through N9) subtypes have been identified [42]. AI
viruses are usually found in wild birds but can also infect people, pigs, horses and other animals.
In Asia and Europe [43], numerous outbreaks of AI virus have been reported in recent years. The
economic significance of AI is substantial. According to CDC [44], the direct economic loss
could be up to hundreds of billion dollars.
1.6.2 Insulin
Insulin is a hormone responsible for glucose metabolism. Insulin is produced in the pancreas
within the β-cells of the islets of Langerhans. Diabetes mellitus (DM) is a disease where the
patient has difficulties in maintaining normal blood glucose levels. DM is mainly caused when
insufficient insulin is produced by the β-cells in the pancreas, or the patient’s body is unable to
effectively utilize the insulin produced. The presence of high blood glucose levels in a patient
can induce secondary complications such as nephropathy and retinopathy. The presence of low
blood glucose levels is known as hypoglycemia which can lead to insulin shock as well as death.
There are three main types of DM, namely, type I (insulin dependent), type II (non-insulin
dependent) and Gestational DM [45]. Type I DM is caused by an auto-immune reaction where
the body’s defense system attacks the insulin-producing cells. Patients with type 1 DM produce
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very little or no insulin. Type I DM can affect people of any age, but mostly occurs in children or
young adults. Type II DM accounts for at least 90% of all cases of diabetes and is characterized
by insulin resistance and relative insulin deficiency. The occurrence of type II DM is typically
seen in patients over the age of 40 but can occur earlier, especially in populations with high
diabetes prevalence [45]. Gestational DM is a type of diabetes that causes high blood glucose
levels in a patient during pregnancy. It develops in one in 25 pregnancies worldwide [45].
Gestational DM usually disappears after pregnancy, but patients and their offspring are at an
increased risk of developing type II DM later in life. Diabetes is a chronic disease and has
reached epidemic proportions in recent years. The prevalence of diabetes for all age groups
worldwide by the year 2030 has been estimated to be 7.8% by the International Diabetes
Federation [46]. The total number of people with diabetes is projected to rise from 171 million
in 2000 to 439 million by 2030 [46].
Insulin monitoring is very important for clinical diagnosis of DM and several analytical methods
have been devised for insulin detection. Some of these analytical methods reported include
immunoaffinity chromatography with subsequent liquid chromatography/mass spectrometry
analysis [47] immunoassays [48], imaging ellipsometry [49], electrochemical [50], amperometric
[51], surface plasmon resonance [52] and mass-sensitive biosensors [53]. The efficiency of
biochemical tests for disease diagnosis is determined by its sensitivity, specificity and time taken
for obtaining the test results. There is a large demand for the development of inexpensive and
easy to perform clinical diagnostic methods, which can provide fast and reliable measurements
of the metabolic parameters of a human body with minimum invasion.
Type II DM has been observed [54] to be a progressive disease with the reduction in the
pancreatic β-cell function commencing 10-12 years before diagnosis. By the time most patients
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are diagnosed with type II DM, their pancreatic β-cell function may have deteriorated up to 50%.
The reduction in β-cell function can lead to insulin deficiency and monitoring the insulin level
can be highly useful to predict the occurrence of type II DM in a patient. The current methods
for insulin detection are based on large automated immunoassay analyzers. These large analyzers
are expensive and are not suitable for point-of-care-testing in a physician’s office.
1.7

Conventional Biodetection Methods

The conventional biosensing techniques are listed in Figure 1.3. Morphological methods are
performed by using microscopic techniques such as bright field, scanning electron microscopy
(SEM) and atomic force microscopy (AFM). Morphological methods are more suitable for
qualitative analysis than quantitative analysis. The sample preparation steps can be time
consuming and in some cases, the sample preparation method can alter the morphology of the
sample being investigated.

Conventional
Biodetection

Morphological
method

Culture and
Colony counting
method

Immunology
based method

Polymerase
Chain Reaction
(PCR)

Figure 1.3 Conventional biodetection methods
Culturing and colony counting (CCC) method is performed by growing and multiplying the
pathogens in a culture media such as agar under controlled laboratory conditions. CCC methods
used for bacterial detection are cumbersome and time consuming, typically require weeks to
complete, involving sequential steps for pre-enrichment, selective enrichment, selective plating
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and subsequent biochemical and serological confirmation [55]. Immunology based method
involve antigen-antibody reactions. Examples of immunology based methods include enzyme
immunoassay (EIA) [56], enzyme linked immunosorbent assay (ELISA) [57], enzyme-linked
immunomagnetic chemiluminescence (ELIMCL) [58], immunomagnetic separation [59],
immune-precipitation assay [60] and western blot test [61]. Some of the problems associated
with immunology based methods are low sensitivity of the assays, low affinity of the antibody to
the analyte/pathogen being measured, and potential interference from contaminants [62].
Polymerase Chain Reaction (PCR) is a nucleic acid amplification technology that was developed
in the mid-80s [63]. It is based on the isolation, amplification and quantification of a short DNA
sequence including the targeted pathogen’s genetic material. A target DNA can be amplified 1million-folds in less than an hour, with sensitivities in theory down to a single target pathogen
[64] and is therefore a widely used detection method for pathogens in food. The PCR method is
less time-consuming than techniques such as like culturing and plating. PCR can take anywhere
from 5 to 24 h to produce a detection result depending on the type of PCR variation used and this
time frame does not include any previous enrichment steps. A false negative PCR test result can
occur due to interference with target-cell lysis necessary for nucleic acid extraction, nucleic acid
degradation and/or direct inhibition of the PCR. The disadvantage of PCR based methods is that
it is expensive, complicated and required highly skilled workers to carry out the tests.
1.7.1 Limitations of Conventional Biodetection Methods
In order to prevent the spreading of diseases, prevent a pandemic and obtain important
epidemiological information about any pathogen outbreaks, the industry needs a reliable,
specific, sensitive, and rapid method for biodetection. The earlier the pathogen outbreak is
detected the easier it is to prevent a pandemic by adopting appropriate confinement strategies.
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The earlier the symptoms of a disease such as cancer/ diabetes are detected through clinical
diagnostics, the better are the chances of a successful treatment. Most of the conventional
methods are effective but are time consuming and required highly skilled professional to perform
them. Also, the test sample needs to be transported to dedicated laboratories where these tests are
performed. There is a need for a technology that can enable rapid, reliable, simple and sensitive
detection. In addition, it should be capable of in-situ real-time monitoring at a low cost. In recent
years, there has been much research activity in the area of biosensor development for detecting
pathogens and physiologically relevant biomolecules. Biosensors are expected to address the
limitations of traditional methods by enabling much faster detection schemes.
1.8

Biosensor

A biosensor is a sensing device comprising of a bio-recognition element and a transducer. A biorecognition element specifically identifies and interacts with an analyte and the changes in its
physicochemical properties (optical, thermal, electrical and thermodynamic properties) are
usually converted into an electrical signal by a transducer. Figure 1.4 shows the schematic of a
biosensor. The bio-recognition element is a sensing material and may include enzyme,
antibodies, microorganism, tissues, organelles and DNA/RNA [65]. The biosensors can be
classified based on the type of bio-recognition element or the transducing method used. Based on
the bio-recognition element, the biosensors can be classified as enzyme sensors, immunosensors,
nucleic acid probe sensors, cell-, tissue- and organelle based sensor. Based on the transducing
method, biosensors can be classified as piezoelectric biosensor, optical biosensor and
electrochemical biosensor.
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Figure 1.4 Schematic of a biosensor
1.8.1 Bio-Recognition Element
Antibody based sensors, also known as immunosensors, are based on the specificity of antibodyantigen reaction to produce a change in the transducer signal. Both polycolonal and monoclonal
antibodies can be used and the suitability depends mainly on their specificity. Antibodies can be
directly immobilized on the surface of the transducer by covalent bonding through amino,
carboxyl or aldehyde groups. Antibodies can also be attached to the surface of magnetic beads to
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perform immunomagnetic separation and detection. Antibody based biosensors with various
transducing methods have been previously reported. For example, immunosensors have been
designed for monitoring cancer cells [66], for cancer marker cell detection [67], for bacteria and
virus determination assays [68], for toxins [69], etc. Enzyme based biosensors are based on using
enzymes which are specific to the biomolecules under detection to catalyze the generation of a
product which can be quantified by a transducer. Most of the enzymes used in biosensors are
oxidases that react with dissolved oxygen to produce hydrogen peroxide. For example,
oxidoreductase enzymes have been used for the detection of lactate [70], alcohol [71],
cholesterol [72], etc. Nucleic acid based biosensors integrate a natural and biomimetic form of
oligo- and polynucleotides and rely on the very strong base pair affinity between complementary
sections of nucleotide strands for their high sensitivity and selectivity. In recent years, the use of
synthetic oligodeoxyribonucleotides (ODNs) is gaining popularity. End-labels, such as thiols,
disulfides, amines, or biotin, are incorporated to immobilize ODNs to the surface of a transducer
element. Electrochemical DNA biosensors where the base-pair recognition event is converted
into a measurable electrical signal are being used for the diagnosis of genetic diseases,
pathogens, biomolecules of clinical interest, etc. [73] reported a low-density electrical 16S rRNA
specific oligonucleotide microarray for detecting pathogens such as E. coli, Pseudomonas
aeruginosa, Enterococcus faecalis, Staphylococcus aureus, and Staphylococcus epidermidis.
1.8.2 Transducer element
Optical biosensors include surface plasma resonance (SPR) biosensor, adsorption and reflection
biosensor, luminescence biosensor, fluorescence biosensor and optical fiber biosensor. SPR and
fluorescence biosensors are the most popular optical biosensors. Fluorescence biosensors use
fluorescent labels for signal generation and the intensity of the fluorescent signal is used to
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determine the amount of the antigen being detected [74].

SPR is a direct optical-sensing

technique that measures the refractive index change due to bio-specific interactions occurring in
the vicinity of a thin metal film surface [75]. SPR biosensors for detecting influenza virus [76]
and plant virus [77] have been reported. Piezoelectric biosensors consist of mass-sensitive
piezoelectric crystals with excitation electrodes. The piezoelectric transducers allow a binding
event to be converted into a measurable signal, such as resonant frequency changes [78]. The
most popular transducer design is based on the quartz crystal microbalance (QCM), adapted to
the liquid medium, which gives a direct response signal to characterize the binding event
between a sensitive layer grafted onto the surface transducer and the analyte to be detected [78].
QCM has been used for the detection of DNA, protein–ligand interactions, virus capsids,
bacteria, and mammalian cells [79]. A microcantilever is another type of mass-sensitive
biosensor. The principle of this detection is based on the change in the mechanical response of a
cantilever due to molecular adsorption on the functionalized cantilever surface. The sensitivity of
a microcantilever is high enough to detect a single virus particle [80]. Electrochemical biosensors
can be classified into amperometric, potentiometric and impedance biosensors based on the
electrical parameters they measure. Potentiometric biosensors use ion-selective electrodes (ISE)
and ISFET to measure the change in electric potential due to the accumulation of ions resulting
from an enzyme reaction [81]. Amperometric biosensors measure the change in electrical current
(typically in the nA to µA range) due to the oxidation/reduction process of an electroactive
species. The working electrodes are usually a noble metal or a screen-printed layer covered by a
bio-recognition element [82]. The amperometric biosensors are often used for analytes such as
glucose, lactate [83], and sialic acid [84]. In addition, the detection of biological agents such as
Bacillus

cereus

and

Mycobacterium smegmatis
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[85],

the serological

diagnosis

of

Francisellatularensis [86], pesticides and nerve agents [87] have been reported. Potentiometric
biosensors measure the potential difference generated across an ion-selective membrane
separating two solutions at virtually zero current flow. A potentiometric sensor array [88] for
investigating the cytotoxicity of hydroquinone to cultured mammalian V79 cells has been
reported. Impedance biosensors are based on the combined measurement of the resistive and
capacitive properties of the targets in response to a small amplitude sinusoidal excitation signal
[89-90]. Impedance detection involves measuring the change in impedance caused by the
binding of analytes to receptors (antibodies, DNA, proteins etc.) immobilized on the surface of
electrodes [91-93], change in the conductivity of the medium caused by the growth of bacteria
[94-96], bacterial cells captured on an electrode surface using Dielectrophoresis [97-100], and
change in the ionic concentration of a medium caused by activity of enzyme used as labels [101104]. Calorimetric biosensors are based on measuring the heat of a biochemical reaction at the
sensing element. These biosensors consist of temperature sensors with immobilized
biomolecules. Once the analyte comes into contact with the biomolecules, the reaction
temperature is measured. The total heat produced or absorbed is proportional to the molar
enthalpy and the total number of molecules in the reaction. The change in temperature is
proportional to the analyte concentration. Calorimetric biosensors have been used for food,
cosmetics, pharmaceutical and other analysis. For example, a microcalorimetric sensor has been
used for L-malic acid determination [105] in various types of food.
1.9

Immunoassay

Immunoassay is a technique that exploits the sensitivity and specificity of antibody-antigen
interactions for the detection of relevant analytes [106]. Immunoassays are routinely used for the
quantification of proteins and small molecules in medical diagnostics, proteomics,
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pharmaceutical and biological research [106]. Immunoassays can be broadly classified into
homogenous and heterogenous immunoassay. In homogenous immunoassays, antibodies and
antigens interact within a solution. In heterogeneous immunoassays, antibodies are immobilized
on a solid support and interact with the antigen at the boundary layer. For example, the
antibodies can be immobilized on the surface of micro and nano beads. The micro and nano
beads can be either paramagnetic or non-magnetic.
1.9.1 Pretreatment of Biological Samples
A sample pretreatment and enrichment step is necessary for detecting biological samples at very
low concentrations. A generic analytical procedure [107] can be broken down into three broad
categories as shown in Figure 1.5: the analytical principle on which the measurement is based,
the analytical method which is the concept for optimizing the conditions of the analytical
principle chosen, and the analytical procedure which includes all considerations from the analyte
to the analytical result. It is necessary to pretreat raw biological samples (from body, laboratory
or field) to ensure that the analyte to be detected is present in a form compatible with the
measurement process and also be free of any foreign substance that may interfere with the
accuracy of measurement. In a traditional sample pretreatment process, several steps that require
the use of large-scale equipment such as high-speed centrifuge and shaker are involved.
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Figure 1.5 Schematic of a general analytical process
1.9.2 Micro/Nano Magnetic Bead Immunoassay
Microbeads are widely used due to their high surface area to volume ratio and ability to function
as a simple mechanism of delivering antibodies to desirable locations within the microfluidic
device [108]. Microbeads can be either magnetic or non-magnetic. For non-magnetic beads, they
can be physically retained by dam-like microstructures [109] to facilitate the removal of unbound
analytes. Alternatively, this can be achieved through the use of dielectrophoresis [110] or
electrostatic forces [111]. The use of magnetic beads eliminates the need for retention
microstructures. In magnetic bead based immunoassays, antibody coated magnetic beads can be
immobilized on the device surface [112] or on the sensor surface [113]. The manipulations of
magnetic beads can be accomplished in two ways: (1) by placing a permanent or electro magnet
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outside the device, and (2) by fabricating the magnet inside the device. Approach (1) has the
advantage of ease of fabrication and low cost. Approach (2) allows a more precise control of the
field strength and direct contact with the magnetic beads.
1.9.3 Immunomagnetic Separation
In recent years, the use of micro or nano superparamagnetic (SPM) beads in immunological
assays has increased as the magnetic properties are shown to improve the assay sensitivity and
duration [114]. In a magnetic immunoassay, the SPM beads are coupled with the target analyte
using various immobilization techniques. One of these techniques is the antibody-antigen
complex. The various steps of an immunomagnetic separation technique are illustrated in Figure
1.6. In this process, the SPM beads are first activated with functional groups that can bind to an
antibody (Ab) specific to the target analyte. Upon mixing with the test sample containing the
analyte, the Ab-SPM beads complex selectively capture the target analyte. The use of Ab-SPM
complex provides a more efficient interaction between the capture Ab and the target analyte,
when compared to Ab immobilized on the bottom of a microwell. The Ab-SPM particle complex
with captured target is then magnetically separated by subjecting the test sample to a magnetic
field. Magnetic separation techniques have much higher separation efficiency when compared to
centrifugation [114].
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Figure 1.6 Basic steps of immunomagnetic separation (a) Introduction of the beads and the
analyte mixture, (b) mixing and binding of the target analyte to Ab-SPM complex (c) magnetic
separation of the Ab-SPM complex and target analyte conjugate, (d) washing of the non-target
entities and background fluid by buffer
1.10 Micro Total Analysis System
In 1990, a new paradigm of integrated microfluidic devices, the concept of miniaturized total
chemical analysis system (TAS) or µTAS was proposed by [115] in which silicon chip analyzers
incorporating sample pretreatment, separation and detection were the key features. Figure 1.7
lists the various components of a µTAS which can be integrated on a single system to automate
various analytical methods. The standard operation of a µTAS includes sample preparation,
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sample injection, fluid and particle handling, reactors and mixing, separation and detection [116].
A fully integrated microfluidic system can be designed to perform all the standard operations of
a µTAS. For example, a cell sample pretreatment step can be performed by micromixing the
cells with fluorescent dyes. These fluorescent labeled cells can then be sorted and transported to
subsequent components for further post-processing steps such as sorting and optical detection.
All the operations of a µTAS are analogous to those performed in a conventional laboratory
using the traditional equipment. A µTAS has the potential to replace the traditional, complicated
biodetection systems and save time and labor.

Figure 1.7 Components of a µTAS

The following sections provide a brief description of the various components of a µTAS.
1.10.1 Microchannels
Microchannels and reservoirs are passive components used to transport and confine microscale
fluids. Microchannels can be defined as channels whose dimensions are less than 1 mm and
greater than 1 μm. Currently, most microchannels fall into the range of 10 to 100 μm.
Microchannels can be fabricated on a wide variety of substrate materials such as glass, polymers
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and silicon. The choice of the material and fabrication methods depend on various factors like
device yield, processing cost, the compatibility between the channel material and the fluid to be
transported (hydrophobic, hydrophilic, chemical resistance, biocompatibility), geometry
constraints like depth, width, surface roughness of the channel surface, and optical transparency
requirements.
1.10.2 Micropump
A micropump is an essential component of a μTAS and delivers fluid between different
components in a controlled manner. Micropumps can be classified into two main categories:
mechanical micropumps and non-mechanical micropumps. Mechanical micropumps can be
further classified into two categories: dynamic pumps and displacement pumps [117]. Dynamic
pumps add energy to the working fluid directly to increase its momentum. A few dynamic
pumps, mostly micro gear pumps, have been reported. For example, a gear micropump
fabricated by LIGA [118] and driven by a small electromagnetic motor, has two opposing in-line
gears (0.6 mm in diameter) and can provide a maximum flow rate of 180 μL/min and a
maximum pressure of 100 kPa while operating at 2250 rpm. Dynamic pumps have moving parts
and have complicated fabrication process. Dynamic pumps with moving parts such as micro
gears can cause damage to bio-samples and are not suitable for biological applications.
Displacement pumps operate by exerting pressure on the working fluid through one or more
moving boundaries. The majority of micropumps are displacement pumps in which the moving
surface is an oscillating diaphragm and also known as diaphragm pumps. Common pump
diaphragm materials reported include silicon [119], glass [120], silicone rubber [121], polyimide
[122], and PDMS [123]. Different actuating mechanisms have been used to drive the diaphragm
including piezoelectric [124], electrostatic [125], thermo-pneumatic [126], pneumatic [127] and
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electromagnetic [128]. Flow rates ranging from as low as 0.0006 mL/min [129] to as high as 16
mL/min [130] have been reported with diaphragm pumps. Non-mechanical micropumps convert
non-mechanical energy (electrical/magnetic) to kinetic energy to add momentum to the working
fluid. Non-mechanical micropumps include electrohydrodynamic (EHD pumps, electroosmotic
(EO) pumps, and magnetohydrodynamic (MHD) pumps. EHD pumps [131-133] utilize
electrostatic forces acting on dielectric liquids to generate flow. One of the fundamental
requirements of EHD pumps is that the fluid must have low electrical conductivity. EO
micropumps [134-136] are based on liquid flow generated by the presence of an electric field
when an ionic solution is in contact with a charged solid surface. EO pumps have the limitations
of high voltage requirement and electrically conductive fluid. MHD pumps are based on Lorentz
force as the driving force with interaction of electrically conductive fluids and magnetic field.
MHD pumps require working fluids with higher conductivity (greater than 1 S/m) and bubble
generation due to ionization is a major drawback.
Micropumps used in μTAS for biomedical applications have requirements such as:
biocompatibility, controllable flow rates, smaller footprints and less power consumptions. In
general, non-mechanical pumps when compared to mechanical pumps have higher power
requirements and limit the electrical properties of the working fluid. Polymer materials such as
PDMS and PMMA are being widely used these days due to their biocompatibility and ease of
fabrication of multilayer monolithic devices. In pneumatically driven diaphragm micropumps,
the choice of the diaphragm material is important and a low-modulus diaphragm material is
widely used to achieve maximum diaphragm deflection for a given driving force. It is also an
advantage to select a diaphragm material such as PDMS that can be readily integrated into an
existing device without affecting the fabrication process. A displacement pump with PDMS as
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the structural material, based on moving membranes actuated in a sequence by external
pneumatic pressure, can meet most of the requirements of a micropump used in μTAS for
biomedical applications.
1.10.3 Micromixer
Micromixer is another important component of a μTAS which often require the mixing of
reactants. Mixing at the micro scale is a challenging task because the flow is laminar and mixing
is dependent on molecular diffusion. Micromixers can be classified into passive and active
devices. Passive micromixers have no moving parts, do not require external energy source and
achieve mixing through the topology of the microfluidic device. Different types of passive
micromixers have been reported: T-mixers [137], Y-mixer [138], injection micromixer [139],
chaotic advection micromixers with obstacles in the fluid path [140], droplet micromixer [141].
Active mixers usually have moving parts and use external energy source to disturb the flow for
mixing. Active micromixers are classified based on the type of external disturbance used.
Examples of active micromixers include T-mixer with pressure disturbance [142], micromixer
with EHD disturbance [150], micromixer with DEP disturbance [151], micromixer with MHD
disturbance [145], micromixer with EK disturbance [146], and micromixer with acoustic
disturbance [147]. In general, active mixers have higher mixing efficiency [148]. Some of the
factors to be considered in selection of the type of micromixer used in a μTAS include the ease
of integration with other components, fabrication material used and compatibility of actuation
mechanism with the overall design of the μTAS. For example, if the fabrication material and
actuation mechanism used for the micromixer and the micropump used in μTAS are the same,
the fabrication process and integration becomes easier.
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1.10.4 Microseparator
The separation of the target biomolecules from a test sample is an important part of the
biochemical analysis. One of the methods for isolating biomolecules of interest from the bulk
sample is by attaching them to functionalized microbeads through a mixing process, followed by
separation of the microbeads. In recent years, various separation techniques have been reported
and most of these involve continuous flow separation where the sample solution is continuously
introduced through a separator device. There are various separation techniques that can be used
for separation of the particles of interest from the test sample. Pinched flow fractionation [149]
and hydrodynamic filtration [150] permit size based sorting of micrometer sized particles.
Filtration obstacle separator [151] is based on flow through an array of pillars where the spacing
between pillars is designed to function as an obstacle to particles in the sample. Lateral
displacement separation [152] is based on pressure gradient from slanted obstacles designed to
perform a size based separation of microparticles, DEP [153] is a separation technique where
non uniform electric field can be used for separation based on the size and polarisibility of
microparticles. In recent times, the use of magnetic micro and nanobeads for immunomagnetic
separation has gained popularity. The use of magnetic microbeads allows for magnetic
separation. The magnets used can be external or integrated within the device. The advantage of
an integrated magnet is that the magnetic field strength requirement is low due to the close
proximity of the magnetic beads to the microfabricated magnet. Several integrated
electromagnets such as the meandering permalloy-core, copper-wire design [154], the spiral
design [155] and the serpentine copper-wires with a semi-encapsulated permalloy [156] have all
been explored. However, the process of integrating microfabricated magnets with a microfluidic
device takes many complicated fabrication steps, which make the approach costly. External
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permanent magnets used for magnetic bead based immunoassay are usually Neodymium Iron
Boron (NdFeB) magnets with a magnetic flux density up to 500 mT at the pole surface [157].
External electromagnets have the advantage of switching on and off and their field strength can
be varied. However, electromagnets have not been as popular as permanent magnets because
even with a large number of windings and high currents, it is difficult to build a small
electromagnet with field strength comparable to a small NdFeB magnet. Also, electromagnets
also have a joule heating problem.
1.10.5 Microsensor
The different types of biosensors based on the bio-recognition element and the transducer
element are discussed in the previous section. The biosensors can also be broadly classified into
label-free and labeled biosensors. In case of the labeled biosensors, labels such as fluorescent
tags, luminescent compounds or radioisotope labels are attached to the target molecule to
enhance signal generation and visualization. The labeling methods are time consuming and
complicated and can substantially increase the assay complexity. Additionally, the attachment of
labels can interfere with the molecular reaction and labeled biosensors cannot be used for real
time measurements. A label-free biosensor on the other hand can be used for direct real time
detection involves lesser assay complexity and is noninvasive in nature. Label free assays are
faster than the labeled ones because they do not need additional incubation time and activation
step for the attachment of labels. Several biosensors such as SPR, QCM, impedance biosensor,
fiber optic immunoassay and magnetoelastic-immunosensors have been developed. Among the
label-free biosensors, the impedance biosensors have added advantages due to their simplicity of
operation and the speed of assay. Also, impedance biosensors have no moving parts and are
easier to fabricate and integrate within a point-of-care testing device.
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1.11 Primary Objectives of Study
The primary goal of the study is the development of a PDMS based µTAS for rapid, multipurpose, impedance based detection of biomolecules.

The following objectives have been

established to attain the primary goal.
1. Design, fabrication and testing of pneumatically actuated PDMS based micropumps
2. Design, fabrication and testing of pneumatically actuated PDMS based active
micromixers
3. Integration of micropump and micromixer with interdigitated electrodes (IDE) for
impedance measurements
4. Numerical simulation of microfluidic components using COMSOL MultiphysicsTM
5. Development of magnetic microbead separation scheme
6. Application of integrated microfluidic system towards biotin conjugated fluorescent
(BCF) microbead detection based on streptavidin-biotin conjugation reaction.
7. Application of integrated microfluidic system towards immuno microbead based insulin
detection
1.11.1 Specific Tasks
The individual tasks associated with the primary areas described previously are listed below.
i. Design, fabrication and testing of pneumatically actuated PDMS based micropumps
1. Mask design and fabrication of SU-8 mold
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2. PDMS casting and oxygen plasma bonding followed by packaging
3. Flow characterization of three different designs of micropump
ii. Design, fabrication and testing of

pneumatically actuated PDMS based active

micromixers
1. Mask design and fabrication of SU-8 mold
2. PDMS casting and oxygen plasma bonding followed by packaging
3. Mixing efficiency characterization of three different designs of micromixer
iii. Integration of micropump and micromixer with IDE for impedance measurements
1. Mask design for integrated device and SU-8 mold fabrication
2. PDMS casting and oxygen plasma bonding followed by packaging
3. Flow characterization of micropump
4. Mixing efficiency characterization of the micromixer
iv. Development of magnetic microbead separation scheme
1. Selection of permanent magnet and configuration to optimize microbead separation
2. Separation efficiency at different sample flow rates
v. Application of integrated microfluidic system towards immuno microbead based insulin
detection
1. Mask design for integrated microfluidic system and SU-8 mold fabrication
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2. PDMS casting and oxygen plasma bonding followed by packaging
3. Testing integrated microfluidic system for detecting BCF microbeads and insulin
1.12 Dissertation Organization
The remainder of this dissertation is divided into six chapters: Chapter 2: Theory and Design,
Chapter 3: Microfabrication, Chapter 4: Experimental Setup and Testing, Chapter 5: Results and
Discussions, Chapter 6: Conclusions and Chapter 7: Future Work. A bibliography of references
is provided at the end of the dissertation. The second chapter provides details of the theory of
operation, mask design and dimensions of the various devices fabricated. The third chapter
describes the microfabrication procedure for all the components of the microfluidic system. The
fourth chapter discusses all the experimental setup and testing protocols used in this study. The
fifth chapter presents and discusses the results of the various experiments and simulations. The
sixth and the seventh chapters summarize the accomplishments of this study and identify the
areas in which future work can be accomplished.
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2. THEORY AND DESIGN
The following sections describe the theory and design of the microfluidic system components
used in the present study. The focus will be on the design of the various components of the
integrated microfluidic system such as micropump, micromixer, microbead magnetic separation
scheme and impedance sensor.
2.1

Micropump

2.1.1 Working Principle
The micropump consists of two PDMS layers bonded together by oxygen plasma bonding. One
of the layers, referred to as the control layer, contains a sequence of air chambers that are
connected via microchannels. The first air chamber has a smaller volume compared to the rest.
The bottom surface of these air chambers is thin and functions as membranes that deflect when
the air chambers are filled with compressed air. The second PDMS layer, referred to as the
fluidic layer has a microchannel through which the fluid is pumped. An external mini air
compressor is used to produce compressed air supply for the micropump. The pneumatic
actuation frequency is controlled via a 3-port ultra-miniature solenoid valve. When a voltage is
applied across the solenoid, the solenoid connects the micropump’s actuator layer inlet to the
compressed air supply. When compressed air is introduced into the air chamber inlet via a
solenoid valve, air fills the three air chambers in a sequence, starting with the smallest chamber.
The membrane of the smallest chamber deflects first and functions as an active valve to
minimize back flow. There is a time delay between the filling of different air chambers due to the
difference in chamber volume and also the presence of the interconnecting microchannels. The
deflection of the membranes in a sequence leads to a peristaltic actuation and causes the fluid in
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the underlying fluidic layer to be squeezed in one direction as shown in the Figure 2.1. When the
solenoid valve is turned off the compressed air is released through the same path it enters the air
chamber and the air chambers are depressurized causing the membrane to move back to its initial
position with zero deflection.
2.1.2 Micropump Geometry
Figure 2.2 shows the various layers of the micropump assembly. Both the PDMS layers have a
glass layer for mechanical support with access holes for inlet and outlet. Three different
micropump design geometries were developed and evaluated in the present study. The three
designs differ in the geometry of the air chambers and the length of the interconnecting
microchannels. The AutoCAD diagrams of the three micropump designs, namely Design1,
Design2 and Design3 are as shown in Figures 2.3, 2.4 and 2.5 respectively. The fluidic layer
microchannel design was the same for all three pumps. Figure 2.6 shows the design of the fluidic
layer microchannel. The design of the air chambers of the control layer is a significant design
parameter, since it governs the dynamic response of the micropump such as the peak operating
frequency and the volume displaced per stroke. In general, large air chambers displace large fluid
volume per stroke and thus lead to a large flow rate. Also, large air chambers require long fill
and evacuate time, thus affecting the peak operating frequency of the micropump. The
interconnecting microchannels between the air chambers provide a time delay between the
sequential actuation of each membrane. This cycle of pressurizing and depressurizing of the air
chambers due to the on-off cycle of the solenoid valve can actuate the fluid flow in one direction
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Figure 2.1 Cross-sectional view of the actuation mechanism of the pump. (1) Liquid enters the
microchannel (2) When compressed air fills the air chambers, the first membrane deflects
downwards (3) – (5) sequential actuation of PDMS membranes causing the liquid to be pumped
to the right.

Glass layer

Control layer

Fluidic layer

Glass layer

Figure 2.2 Various layers of the micropump assembly
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Label
R1
R2
R3
R4
R5
R6
R7
W1

Dimension
(mm)
3.0
0.84
2.41
1.68
2.16
2.54
2.27
0.5

Label Dimension
(mm)
L1
5.8
L2
1.98
L3
4.75
L4
4.82
L5
0.61
L6
0.5
L7
1.98
L8
1.32

Figure 2.3 Micropump Design1 – Control Layer

Label
R1
R2
R3
L1
L2
L3
L4

Dimension
(mm)
1.5
0.25
0.53
7.77
0.62
0.78
1.68

Figure 2.4 Micropump Design2 – Control Layer
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Label Dimension
(mm)
L5
1.86
L6
2.18
L7
1.1
L8
1.8
L9
0.77
L10
0.79
L11
0.13

Label
R1
R2
R3
L1
L2
L3
L4
L5
W1
W2

Dimension
(mm)
1.5
0.75
0.75
7.93
2.13
0.74
1.17
1.06
0.23
0.13

Figure 2.5 Micropump Design3 – Control Layer

Label Dimension
(mm)
L
22
R1
1.5
W
0.5

Figure 2.6 Fluidic layer microchannel design
2.2

Micromixer

2.2.1 Working Principle
The micromixers used in this study utilize oscillating membranes to achieve active mixing. The
micromixer consists of two PDMS layers bonded together by oxygen plasma bonding. One of
the layers, referred to as the control layer, has air chambers. The bottom surface of the air
chambers functions as a membrane that can deflect when the air chamber is filled with
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compressed air. An external mini air compressor is used to produce compressed air supply for
the micromixer. The pneumatic actuation frequency is controlled via a 3-port ultra-miniature
solenoid valve. When a voltage is applied across the solenoid, the solenoid connects the
micromixer’s actuator layer inlet to the compressed air supply, causing the membranes to deflect.
The second PDMS layer, referred to as the fluidic layer, has a mixing chamber with two inlets
and one outlet. The two PDMS layers are bonded together by oxygen plasma bonding, with the
mixing chamber in alignment with the air chambers. A set of glass layers with access holes to the
inlet and outlets of the PDMS layers provide mechanical support. Figure 2.7 illustrates the
motion of the micromixer membrane during one actuation cycle.

Figure 2.7 Working of a micromixer with two pneumatically actuated membranes

41

These PDMS membranes can be moved up and down sequentially and the membrane deflection
generates fluid convection in the mixing chamber. This agitates the mixing species leading to
better mixing. When the solenoid valve is turned off the compressed air is released through the
same path it enters the air chamber and the air chambers are depressurized causing the membrane
to move back to its initial position with zero deflection.

Glass layer

Control layer

Fluidic layer

Glass layer

Figure 2.8 Various layers of the micromixer assembly
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2.2.2 Micromixer Geometry
In the present study, three different micromixer design geometries were developed and
evaluated. The primary difference between these designs is the membrane configuration in the
control layer and the interconnecting delay microchannels. Design1, as shown in Figure 2.9, uses
two independently operated semi-circular membranes to achieve mixing. Design2, as shown in
Fig. 2.10, utilizes four separate quadrant membranes which can be independently controlled.
Design3, as shown in Figures 2.11a and 2.11b, uses 6 membranes that can deflect in a sequence.
In Design3, unlike Designs 1 and 2, the air chambers are interconnected in series by
microchannels (100 µm x 100 µm). The first air chamber in the series is connected to the
compressed air source and the interconnecting microchannels provide the delay between the
sequential actuation of each membrane. The fluidic channel layer for all the micromixers is the
same and consists of a circular mixing chamber with two inlets and one outlet. Figure 2.12 shows
the design geometry of the fluidic layer of the mixer.

Label Dimension
(mm)
L1
8.7
L2
0.86
R1
1.5
R2
1.5
D1
0.1
Figure 2.9 Micromixer Design1 control layer with two semi-circular air chambers
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Label
R1
R2
L1
L2
L3
L4

Dimension
(mm)
1.5
1.5
10
8.6
10
8.6

Figure 2.10 Micromixer Design2 control layer with four quadrant air chambers

Label Dimension
(mm)
L5
4.8
W2
0.14
R2
1.5
W
0.04
L1
0.1
L2
0.05
L3
0.12
G
0.17
L4
0.7
(a)

(b)

Figure 2.11 (a) Micromixer Design3 control layer with six air chambers connected in series (b)
Close up view of the Design3 air chambers
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Label
R1
L1
L2
W1
R2
L3
W2

Dimension
(mm)
1.5
7.5
3.2
0.2
2
8
0.1

Figure 2.12 Fluidic layer of the micromixer with a mixing chamber
2.3

Integration of Micropump and Micromixer

The individual micropumps and micromixers were tested for their performance. Among the
micropump and micromixer designs, Design3 of the micropump and Design3 of the micromixer
were selected for integration into a single microfluidic system. The performance and selection
criteria for the micropump and micromixer will be discussed in Chapter 5 (Results and
Discussions). The control layers of selected micropump and micromixer designs were combined
into a single PDMS control layer to achieve an integrated micromixer-micropump system. Figure
2.13 shows the various layers of the fully integrated micromixer-micropump system. The design
of the fluidic layer for the integrated micromixer-micropump system is shown in Figure 2.14.
Figure 2.15 shows the alignment of the control layer on top of the fluidic layer of the integrated
micromixer-micropump system. The important alignment requirements are to center the
micromixer air chambers with the mixing chamber below and position the micropump air
chambers on top of the microchannel.
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Glass layer

Control layer
(micropump &
micromixer)

Fluidic layer

Glass layer

Figure 2.13 Different layers of the integrated micromixer-micropump assembly

Label
R1
W1
L1
W2
L2
R2
L3

Dimension
(mm)
1.5
0.5
8.5
0.7
10
1.125
3

Figure 2.14 Fluidic layer of the integrated micromixer-micropump
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Label
S1
S2

Dimension
(mm)
0.7
4.3

Figure 2.15 Alignment of the layers of integrated micromixer-micropump
2.4

Impedance Spectroscopy (IS)

The electrical impedance Z of a system can be determined by applying a small amplitude voltage
perturbation to the system and then measuring the current response. Z is the ratio of the voltage time function V (t) and the resulting current-time function I (t)
()
()

(

(2.1)

)

where Vo and Io are the peak voltage and current, f is the frequency, t is the time, Φ is the phase
shift between the voltage-time and current-time functions, and Y is the complex conductance or
admittance. Z is a complex function and can be described by the modulus |Z| and the phase shift
Φ or by the real part ZR and the imaginary part ZI, as illustrated in Figure 2.16 The impedance
data can be plotted in two different ways: the Bode plot which plots log |Z| as a function of log f,
or the Nyquist plot which plots ZR versus ZI. The name IS refers to the fact that impedance
generally varies with frequency. The impedance spectrum is often analyzed using the theory of
equivalent circuit, which uses circuit elements such as resistances and capacitances to represent
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the various physicochemical properties of the system under study [158]. The experimental data is
curve-fitted by the equivalent circuit model using non-linear least square fitting techniques.

Figure 2.16 Components of Impedance
2.4.1 Impedance Spectrum Measurement for a Microfluidic System
An impedance measurement setup for a microfluidic system typically consists of at least two
electrodes within an electrode cell which contains the test sample. An impedance analyzer is
connected to the electrodes to perform an impedance scan. A schematic of the impedance
measurement scheme is shown in Figure 2.17. The impedance analyzer applies an AC voltage
perturbation and the current flows through all components of the system, the electrodes, the
suspension medium and the analyte.
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Figure 2.17 Impedance spectrum measurement setup for a microfluidic system
The measured impedance is therefore the sum of the contributions from all the components of
the system. Some of the latest impedance analyzers also contain post-processing capabilities to
perform equivalent circuit analysis. The impedance spectrum is measured as a function of the
concentration of the analyte in the suspension medium. The frequency range of the impedance
measurement can vary with the system under study but usually ranges from 5 Hz up to 10 MHz.
The suspension medium can be used as the control/reference in impedance measurement. The
impedance data for various analyte concentrations is compared with the control data to determine
the change in impedance caused by the presence of analyte in the suspension medium.
2.4.2 Design of Interdigitated Electrode (IDE)
The electrode configuration for impedance measurement can be IDE, double or triple electrodes.
The choice of electrode material is also important because it can affect the chemistry and ease of
functionalization of the electrode surface. Other selection criteria include durability and stability
under measurement conditions, the possibility of cleaning and sterilizing the electrode surface
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and biocompatibility. The most common electrode material is gold, but platinum and carbon
electrodes have also been reported. Gold is a very good electrode material due to its relatively
fast electrode kinetics and the possibility of forming self-assembled monolayers (SAM) to
immobilize biorecognition element on the electrode surface. IDE is highly desirable in
impedance measurement because of its well-defined geometry and reproducibility in fabrication
[159]. IDE consists of multiple leads with branched electrode fingers interwoven between the
leads [160]. Figure 2.18a shows a basic IDE configuration, including the electrical contact pads,
side rails and interdigitated fingers. Figure 2.18 (b) shows the various design dimensions of an
IDE configuration. In Figure 2.18 (b), L is the length of the electrode finger, W is the width of
the electrode finger, S is the spacing between the electrode fingers, G is the gap between side rail
and finger, A is the width of bond pad, B is the length of bond pad, C is the length of connection
between bond pad and side rail. Figure 2.19 shows the various layers of an IDE chip assembly.
The sensing area of the IDE is the region between the opposing electrode rails. The performance
of the IDE for impedance measurements in a microfluidic chamber depends on the geometric
design of the IDE and can be significantly impacted by variability or defects in manufacturing or
material [160]. Several IDE configurations were designed and included alterations to the width
of the electrodes, spacing between electrodes and the number of pairs of electrodes. The
electrode material was gold for all designs. Table 2.11 lists the various IDE configurations used
in the present study.
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(a)

(b)

Electrical
contact pad

W
C

side rail

finger

L

G
N = number of fingers
S
A
B

Figure 2.18 (a) Basic IDE features (b) Dimensions of IDE
Name
Design 25-10
Design 25-ext
Design 25-int
Circular

N
20
50
50
50

S (µm)
20
20
20
20

W(µm)
L(mm)
20
0.9
20
2.83
20
0.89
20
0.79-1.75

A(mm)
4
4
4
4

B(mm)
4
4
4
4

Table 2.1 Design dimensions of various IDE designs
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C(mm)
16.6
16.6
16.6
17

G(µm)
50
100
50
50

Glass layer

Fluidic layer

IDE chip

Figure 2.19 Various layers of an IDE chip assembly
2.5

Magnetic Separation Techniques

The magnetic force acting on a single magnetic particle is given by [161]
(2.2)
where

is the magnetic density gradient,

the volume of the magnetic particle, and

is the susceptibility of the magnetic particle,

is the permeability of free space. If the magnetic

particle moves in a suspension medium, it also experiences the hydrodynamic drag
gravitational forces
(

is

and

and can be calculated using the following equations.
)

(2.3)
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(
where

)
,

,

and

(2.4)
are the particle velocity, medium velocity, particle density

and medium density, respectively. Solving for (
(

)

(

) for a particle with radius R,
)

(2.5)

The hydrodynamic drag force is the most significant force acting against the magnetic force on
the bead. The magnetic capture force will dominate when
(2.6)
2.6

Integration of Micropump, Micromixer, and IDE

A systematic study was carried out to determine the performance of the various designs of
micropumps and micromixers. Based on the results (to be discussed in Chapter 5), Design3 of
micropump and Design3 of micromixer were selected for the fully integrated microfluidic
system. The fully integrated microfluidic system consists of a PDMS control layer with the
micromixer and micropump, a PDMS fluidic layer with the mixing chamber and an IDE on glass
substrate. The PDMS fluidic layer and the IDE on glass substrate are aligned such that the
mixing chamber covers the IDE. Figure 2.20 shows the various layers of the fully integrated
microfluidic system. Figure 2.21 shows the outer dimensions of the control layer. Figure 2.22
shows the dimensions of the fluidic layer. Figure 2.23 shows the outer dimensions of the IDE
chip. Figure 2.24 shows the outer dimensions of the alignment.

53

Glass layer

Control layer

Fluidic layer

IDE chip

Figure 2.20 Different layers of the fully integrated device assembly

Label
D1
L1
W1
D2
D3
D4

Dimension
(mm)
25
75
45
10
15
40

Figure 2.21 Outer dimensions of the control layer
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Label
R1
L1
L2
W1
R2
L3
W2

Dimension
(mm)
1.5
7.5
3.2
0.2
2
8
0.1

Figure 2.22 Outer dimensions of the fluidic layer

Label
W
L
Y
X

Dimension
(mm)
50
75
25
5

Figure 2.23 Outer dimensions of the IDE layer

Label
D1
D2

Dimension
(mm)
20
20

Figure 2.24 Outer dimensions of the alignment
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2.7

Biotin-Streptavidin Interactions in Assay Systems

Streptavidin is a protein with four identical subunits, each containing a high affinity binding site
for biotin (also known as vitamin H). The dissociation constant KD of the biotin-streptavidin
complex is on the order of ~10-15 which is among the strongest non-covalent interactions known
in nature and about 103-106 times greater than the interaction of ligands with their specific
antibodies [162]. This high dissociation constant ensures that once a streptavidin-avidin complex
is formed, the complex is not affected by any pH changes, presence of chaotropes, or any
washing steps required for the protocol. The biotin-streptavidin interaction is a widely used
affinity pair in molecular, immunological, and cellular assays. The specificity of biotinstreptavidin complex has been used as a basis for developing assay systems to detect or quantify
analytes. A common application for biotin-streptavidin interaction is in immunoassays. The
specificity of antibody molecules provides the targeting capability to recognize and bind
particular antigen molecules. If biotin labels are attached to the antibody, and the streptavidin is
in turn labeled with a signal generating substance such as an enzyme or fluorophore, then a very
sensitive antigen detection system can be created based on the biotin-streptavidin reaction.
2.7.1 Biotin-Streptavidin Conjugation Reaction
The biotin-streptavidin conjugation reaction was utilized in the present study to determine the
performance of the micromixer and also to test the fully integrated microfluidic system for the
detection of biotin conjugated fluorescent (BCF) microbeads. In this study, two surface
functionalized beads were used: BCF microbeads and streptavidin conjugated paramagnetic
(SCP) microbeads. The details of the BCF and SCP microbeads are mentioned in Chapter 4.
After mixing, the biotin-streptavidin complex can be magnetically separated as depicted in
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Figure 2.25 and the fluorescence signal from the biotin coated fluorescent beads can be measured
using a fluorometer to estimate the quantity of the biotin-streptavidin microbead conjugates. The
intensity of the fluorescence signal indicates the extent of the binding reaction between the two
functionalized beads and indirectly indicates the performance of the micromixer.

Biotin molecule

BCF bead

Streptavidin molecule

wash with buffer
micro-centrifuge wall

conjugated
BCF beads

magnetic field
from magnetic
separation stand

unconjugated
BCF beads
washed away

Figure 2.25 Biotin Streptavidin conjugation reaction
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2.8

Insulin Detection

The fully integrated microfluidic system was tested for the immuno microbead based insulin
detection. The details of all the chemicals, microbeads, type of insulin and insulin antibody used
are mentioned in Chapter 4. Figure 2.26 shows the various steps used in preparation of samples
and the insulin detection protocol used in the present study.
The carboxyl groups on the surface of the microbeads are first activated by combining with
EDC. The activation of the carboxyl groups allows it to covalently attach to the amine groups on
antibodies. The activated magnetic beads are combined with the unconjugated mouse anti-insulin
(1G11) monoclonal antibody (MAI-Ab) to yield Magnetic Beads-Antibody Conjugate (MBAC).
The prepared MBAC is then mixed with target insulin molecules to allow binding reaction
between target insulin molecules and MAI-Ab. An external magnet is used to separate the
MBAC-target insulin complex from the solution. The unbound target insulin molecules are
removed by washing with a buffer solution. The wash step is followed by an impedance
spectrum measurement.
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Figure 2.26 Basic steps in insulin sample preparation (a) Introduction of MBAC target insulin,
(b) mixing and binding of the target insulin to MBAC (c) magnetic separation of the target
insulin and MBAC complex, (d) washing of the unbound insulin by buffer
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3. MICROFABRICATION
The microfabrication methods for the various components of the microfluidic system are
described in detail in this chapter. The microfluidics components including the microchannel,
microvalve, micropump and micromixer were fabricated by soft lithography rapid prototyping of
PDMS and SU-8 photoresist. The microelectrodes for the impedance detection module were
fabricated by traditional MEMS based micromachining of Chrome/Gold thin-film layer on a
glass substrate.
3.1

PDMS Soft Lithography

Figure 3.1 demonstrates the process flow used to fabricate the PDMS components. The actual
fabrication was performed at the High Density Electronics Center (HiDEC) of the University of
Arkansas and the Arkansas Micro and Nano Systems Laboratory. The details of the process flow
shown in Figure 3.1 are provided in the following sections.
3.2

Mask Design

All mask designs were drafted using AutoCAD. The mask size was designed to be compatible
with 5 inch wafers. The AutoCAD designs were sent to Advance Reproductions (North Andover,
MA) where transparency photo masks with a ¼ mil resolution were manufactured.

The

transparency photo mask is suitable for designs at a resolution limit of about 15µm. Each photo
mask was cut into a 5” circle and fixed onto a 6” glass substrate using double-sided Scotch tape®.
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Figure 3.1 Soft lithography process flow for a PDMS component fabrication
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3.3

Fabrication of SU-8 Master Mold

Using the transparency masks, SU-8 master molds were fabricated for casting PDMS. The
process flow for the fabrication process is shown in Figure 3.2.
Si wafer

1. Clean silicon wafer

SU-8

2. Spin coat SU-8 and
planarize

3. Pre-exposure bake
Hot Plate

UV light

photo mask
UV filter

4. UV exposure using
mask aligner to
transfer mask pattern

5. Post-exposure bake
Hot Plate
6. Develop in SU-8 developer

7. Hard bake
Hot Plate
Figure 3.2 Fabrication of SU-8 mold
The details of the processing steps are described in the following sections.
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1. A piranha solution was prepared by mixing H2SO4 with H2O2 at the ratio 3:1 and
heated on a hotplate to a temperature of 150ºC. Afterwards, the silicon wafer for the
SU-8 mold was immersed in it for 15 min. Next, the silicon wafer was dump rinsed in
DI water followed by spin rinse and drying. The silicon wafer was then placed in a
buffered oxide etchant (BOE, HF: NH4F= 1:6) solution to strip any silicon dioxide on
the wafer. The silicon was dump rinsed again in DI water followed by spin rinse and
drying. The silicon wafer was placed in an oven for 20 min at 120ºC to remove any
moisture on the wafer surface.
2. The cleaned silicon wafer was mounted on the vacuum chuck of the negative resist
spin coating system. Then approximately 5 mL of liquid SU-8 2075 (MicroChem
Corp., Newton, MA) was dispensed onto the center of the silicon wafer. The wafer
was spun at 500 rpm for 10 seconds followed by 2000 rpm for 30 s to obtain a SU-8
thickness of 100 µm. The spin speed and spin time information was obtained from
the SU-8 2075 data sheet provided by the vendor. After spin coating the wafer was
placed on a flat surface to allow the SU-8 to flow and planarize uniformly across the
wafer surface. This step is very important especially with thin silicon wafers which
bend because they are pulled at the center when placed on the high vacuum chuck of
a spin coater. The absence of edge bead removal during the spin coating step will also
require the planarization step.
3. The pre-exposure bake step was performed in two steps, first step at 65ºC for 5
minutes followed by a second bake step at 95ºC for 20 min. These temperatures and
timings depend upon the thickness of the SU-8 and can information can be obtained
from the data sheet. The hot plate was then turned off to allow the wafer to cool
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down slowly to room temperature. The slow cooling of the wafer is important to
prevent resist cracking and possible delamination.
4. The wafer with SU-8 coating was mounted on a Karl Suss Mask aligner and a
transparency mask with design pattern was placed and aligned on top of the wafer. In
order to obtain vertical side walls in the SU-8 photoresist, a UV filter (PL-360-LP,
Omega Optical, Inc., Brattleboro, VT) to filter out UV radiation below 350 nm, was
placed between the UV light source and the transparency mask. The UV exposure
energy value required for a 100 µm thick SU-8 2075 is 240 mJ/cm2 and was obtained
from the SU-8 data sheet. The exposure time was calculated based on the intensity of
the UV lamp source and was incremented by 20% to account for the presence of the
UV filter.
5. The post-exposure bake was performed on a hotplate in a two-step process to stabilize
the transferred pattern and remove any extra solvents. The first bake step was
performed at 65ºC for 5 min, followed by a second bake step at 95ºC for 10 min. The
hot plate was then turned off to allow the wafer to cool down slowly to room
temperature.
6. The wafer was immersed in a SU-8 Developer (MicroChem Corp., Newton, MA),
developed for 10 min (for 200 µm thick SU-8) and gently moved back and forth to
ensure uniform developing. The wafer was rinsed briefly with IPA and blown dry
with nitrogen.
7. The dried wafer is then hard baked on a hot plate at 150°C for a couple of minutes to
complete the SU-8 patterning process.
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3.4

Thick PDMS Casting

The process flow for casting a thick PDMS layer on a SU-mold is shown in Figure 3.3.

1. Micropump SU-8
mold
2. Pour PDMS and de-gas

3. Cure PDMS at 80°C for 2 hours.
Hot Plate

4. De-molding thick film PDMS
layer

Figure 3.3 Thick PDMS casting process
The details of the thick PDMS casting process are as follows:
1. The PDMS base and curing agent were mixed in a ratio 10:1 by mass in a 2 inch petri
dish. The PDMS mixture is left in the open petri dish for 15 min to get rid of the air
bubbles. Alternatively, the petri dish with PDMS mixture can be left in a vacuum
chamber for a few minutes to degas the air bubbles.
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2. For the thick PDMS layer, the PDMS mixture is poured uniformly to cover the wafer
with the SU-8 mold to a thickness of approximately 5 mm. Any air bubbles generated
while pouring were removed by piercing the bubbles with a syringe needle.
3. The SU-8 mold was then placed on a hot plate at 80ºC for 2 hrs.
4. The cured PDMS layer was diced using a razor blade and gently peeled off from the
SU-8 mold to obtain the thick PDMS component.
Figure 3.4 (a) shows a typical SU-8 mold for a micropump fluidic layer. Figure 3.4 (b) shows a
thick PDMS layer casted by SU-8 mold.

Figure 3.4 (a) Typical SU-8 mold on Si wafer (b) A thick PDMS fluidic layer

3.5

Thin PDMS Casting

The process flow for casting a thin PDMS layer on a SU-mold is shown in Figure 3.5.
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1. SU-8 mold

2. Spin coat PDMS to obtain thin
layer and degas

3. Cure PDMS at 80°C for 2 hours
Hot Plate

4. De-molding thin film PDMS
layer
Figure 3.5 Thin PDMS casting process
The details of the thin PDMS casting process are as follows:
1. PDMS mixture was prepared as described in the previous section.
2. For the thin PDMS layers with membranes, the PDMS mixture was spin coated on
the SU-8 mold at 450 rpm for 1 min to obtain a 100 µm thick PDMS membrane. The
required spin speed was determined from the spin speed vs. thickness plot [163] as
shown in Figure 3.6.
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Figure 3.6 PDMS thickness as a function of spin speed
3. The SU-8 mold was then placed on a hot plate at 80ºC for 2 hrs.
4. The cured PDMS layer was diced using a razor blade and gently peeled off from the
SU-8 mold to obtain the thin PDMS component.
Figure 3.7 (a) shows a typical SU-8 mold for a thin PDMS control layer. Figure 3.7 (b) shows a
thin PDMS layer casted by SU-8 mold.

Figure 3.7 (a) SU-8 mold on Si wafer for thin PDMS control layer (b) A thin PDMS control
layer
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3.6

Oxygen Plasma Bonding

The bonding of a PDMS layer to another PDMS layer or a PDMS layer to a glass substrate was
achieved by oxygen plasma treatment of the bonding surfaces. The PDMS thin layer was first
bonded to a glass slide which provides mechanical support. The PDMS thick layer was then
bonded to the PDMS thin layer. A glass slide was then bonded to the PDMS thick layer. Figure
3.8 shows the process flow for assembling the device.

Figure 3.8 Process flow for assembling the device
The oxygen plasma bonding steps are as described below:
1. An abrasive diamond grinding mandrel (1.5 mm diameter, Wale Apparatus Inc.,
Hellertown, PA) was used to drill holes in the glass slides (75x38 mm, 1 mm
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thick, Electron Microscopy Sciences, Hatfield, PA) for providing access to the
inlets and outlets of the microchannels in the PDMS layer. The glass slides with
drilled holes were cleaned using a Piranha solution to remove any organic
contaminants, rinsed in DI water and blow dried with nitrogen A 1.5 mm tip
diameter micro coring tool (Harris uni-core, Ted Pella, Inc. Redding, CA) was
used to punch holes in the PDMS layers at the microchannel inlet and outlet. The
glass slide and the thin PDMS layer were placed inside the Oxygen plasma
chamber (Model PC-150, South Bay Technology, Inc., San Clemente, CA) with
their bonding sides facing up. The plasma chamber was operated at 20 W, 105
mTorr for 20 s. The exposure to oxygen plasma causes oxidation of the CH3
groups on the PDMS surface to produce OH groups [164]. The –OH functional
groups on the PDMS surface enable bonding to another PDMS surface or glass.
The oxygen plasma treatment also temporarily makes the hydrophobic PDMS
surface to a hydrophilic surface. The plasma treated PDMS layer was held by a
pair of tweezers at the opposite corners, aligned and brought in contact with the
glass slide on one edge of the glass slide first. The PDMS layer was then gently
rolled on top of the glass slide to complete the bonding as shown in Figure 3.9.
This rolling action reduces the trapping of air between the bonded layers and
leads to a uniform bonding. The bonding process has to be completed within 3
minutes of exposure to oxygen plasma in order to ensure complete bonding.
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Figure 3.9 Roll PDMS layer to obtain uniform bonding
2. A 1.5 mm tip diameter micro coring tool was used to punch holes in the thick PDMS
layers at the microchannel inlet and outlet.
3. A similar procedure as described in Step 1 was repeated to bond the thick PDMS
layer to the thin PDMS layers.
4. A glass slide was then bonded to the thick PDMS layer to complete the oxygen
plasma bonding process for the device. The assembled device was then packaged
with fluidic connectors and tubing to obtain the final device.
Figure 3.10(a) shows typical thick and thin PDMS layers of a micropump assembled together
and Figure 3.10(b) shows a close view of the alignment of the air chambers on top of the
microchannel.

Figure 3.10 Thick and thin PDMS layers of a micropump bonded together (b) A close view of
the alignment of the air chambers over the microchannel
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3.7

Fabrication of IDE

Figure 3.11 shows the process flow for fabrication of the IDE.
AZ4110 resist 1. Spin coat AZ4100 and
soft bake
Cr/Au
Glass
Hot Plate

UV light

photo mask
UV filter

2. UV exposure using
mask aligner to
transfer mask pattern

AZ4110
Cr/Au
Glass
AZ4110
Cr/Au
Glass
AZ4110
Cr/Au
Glass
AZ4110
Cr/Au
Glass
Cr/Au
Glass

Figure 3.11 Fabrication steps for IDE
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3. Develop the resist

4. Hard bake

5. Etch Cr/Au

6. Strip resist, rinse
with DI water and dry

The AutoCAD designs were sent to Advance Reproductions (North Andover, MA) where
transparency photo masks with a ¼ mil resolution were manufactured. The transparency photo
mask is suitable for designs at a resolution limit of about 15 µm. The wafers used were 500 µm
thick, 5 in. Glaverbel float soda lime glass wafers (Precision Glass and Optics, Santa Ana, CA).
The details of the processing steps are as described below.
1. The wafers were cleaned in a Piranha solution, rinsed in DI water and spin dried. The
cleaned wafers were then sputtered with Cr/Au (250Å/5000Å, UHV Sputtering,Inc.,
Morgan Hill, CA). The glass wafers with Cr/Au were rinsed with Acetone, rinsed in
DI water and spin dried. The wafers were then left in an oven at 120°C to dry the
wafer surface. The cleaned wafers were spin coated with a 1.25 µm thick layer of
AZ4110 photoresist. After the spin coating, the resist may contain up to 15% solvent
and may have built-in stress. To remove the solvent and reduce the stress, the spin
coated resist was soft baked at 110°C for 4 min.
2. Following this, a Karl Suss mask aligner was used to align and expose the resist
coated wafer to transfer the pattern from the photomask onto the photoresist.
3. Afterwards a development process was used to selectively dissolve the photoresist.
AZ4110. Following development, the wafer was examined visually to ensure that the
development process was complete. A final inspection was made under a microscope
to ensure that the pattern obtained was as expected.
4. Hard bake or post bake removes any residual developer solution and also anneals the
photoresist to promote the interfacial adhesion of the photoresist weakened by
developer entering the resist-wafer interface. Hard baking also improves the hardness
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of the film which is required during further etching steps. The hard bake was carried
out by placing the wafer in an oven at 120°C for 15 min.
5. The wafer was immersed in a gold etchant solution (gold etchant TFA, Transene, Inc,
Danvers, MA) to remove the gold from the exposed regions on the wafer. The etch
rate was 28Å/second at 25°C when the etchant was fresh. This was followed by a Cr
etch using the chromium etchant (1020AC, Transene, Inc.) to remove the chrome
layer. The etch rate was 32Å/s at 40°C.
6. The etched wafers were rinsed with DI water and spin dried.
Figure 3.12 shows a typical IDE chip with holes drilled for access to the inlet and outlet of the
fluidic layer microchannel. Also shown is a close view of the IDE fingers with 10 µm width and
spacing.

Figure 3.12 A typical IDE chip with a close view of the IDE fingers
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3.7.1 PDMS bonding with IDE
The etched wafers were then diced using a wafer dicing machine to obtain the individual
electrode chips. Figure 3.13 shows the process flow.
Cr/Au electrodes
1. Drill access holes and clean.
Glass

inlet

outlet
Glass
Cr/Au electrodes
PDMS microchannel
Glass
2. PDMS channel – O2 plasma bonding

inlet

outlet

Figure 3.13 PDMS bonding to IDE
The details of the processing steps are as described below:
1. An abrasive diamond grinding mandrel was used to drill holes in the electrode
chip to provide inlet and outlet access. The electrode chips were rinsed in DI
water and blow dried with Nitrogen to remove the glass debris produced
during the drilling process. The electrode chips were then rinsed in Acetone
and blow dried with Nitrogen. A PDMS microchannel was bonded to the
electrode chip by using oxygen plasma bonding method as described in the
previous section.
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2. A glass layer was bonded to the PDMS layer to provide mechanical stability.
3.8

PDMS – Glass Thermal Bonding

An alternate method to oxygen plasma bonding is thermal bonding. Thermal bonding provides a
temporary bond unlike the permanent bond achieved through oxygen plasma bonding. Figure
3.14 shows the process flow for PDMS-Glass thermal bonding.

Partially cured
PDMS microchannel
1. Cast PDMS microchannel and
partially cure at 65°C
Cr/Au electrodes
2. Align PDMS microchannel on
Glass electrode chip with holes drilled
for inlet and outlet.
inlet

outlet

Cr/Au electrodes
Glass
Hot Plate

3. Final cure at 80°C for 10 hours

Figure 3.14 PDMS – Glass thermal bonding process
The details of the processing steps are as described below:
1. The PDMS microchannels were casted on a SU-8 mold as described in the
previous sections. The PDMS layer was first partially cured at 65°C for 45
min.
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2. An abrasive diamond grinding mandrel was used to drill holes in the electrode
chip to provide access to the inlet and outlets of the PDMS microchannel. The
electrode chips were rinsed in DI water to remove the glass debris produced
during the drilling process. The electrode chips were then rinsed in acetone to
remove the photoresist. After the acetone rinse most of the photoresist from
the electrode surface is removed. To further clean the electrode surface, a soft
cotton swab dipped in acetone was used to gently clean the electrodes without
scratching the gold surface. The partially cured PDMS is peeled off the SU-8
mold, aligned with electrode chip and aligned on top of the electrode chip.
3. The electrode chip with PDMS is then place on a hot plate at 80°C for 10 hrs
to completely cure the PDMS layer. After the final curing, a glass slide is
attached to the exposed back side of the PDMS channel to provide mechanical
support.
The thermal bonding method, unlike the oxygen plasma treatment bonding method, is reversible.
Therefore, the PDMS layer can be removed and replaced with a fresh PDMS layer when PDMS
surface is contaminated after repeated use or when it is required to clean the electrode surface.
3.9

Fully Integrated Microfluidic System

Figure 3.15 shows a fully integrated microfluidic system. Figure 3.16 shows a close view of the
micropump and micromixer from the fully integrated microfluidic system shown in Figure 3.15.
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Figure 3.15 A fully integrated microfluidic system

Figure 3.16 A close view of the various components on the fully integrated system
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4. EXPERIMENTAL SETUP AND TESTING
The following sections describe the material selection and design of experimental methods used
to test the various microfluidic system components used in this study. The focus will be on
individual testing of various microfluidic components and the integration of various components
to achieve a fully integrated microfluidic system.
4.1

Surface Modification of PDMS

The use of PDMS for microfluidic devices has many advantages as discussed in the previous
section. However, PDMS has a hydrophobic surface and tends to adsorb organic macromolecules
such as protein and causes non-specific protein adsorption which can interfere with biological
applications performed within a PDMS microfluidic system [165]. The hydrophobic surface of
PDMS also leads to formation of air bubbles within a PDMS microchannel. One of the methods
commonly used to modify the hydrophobic surface of PDMS by exposure to oxygen plasma. An
exposure to oxygen plasma oxidizes the surface of the PDMS and makes it hydrophilic.
However, when exposed to air later, the hydrophobic surface recovers with time. With oxygen
plasma treatment, a useful lifetime for quantitative electrophoresis is 3 hrs [166]. In the present
study, the PDMS surfaces were treated with Pluronic F108 surfactant (#F018, BASF, Florham
Park, New Jersey) to modify the PDMS surface to make it hydrophilic and reduce non-specific
protein adsorption. Pluronic belongs to a group of triblock copolymers with poly(propylene
oxide) (PPO) centers with poly(ethyelene oxide) (PEO) side chains with the general composition
of (PEO)m(PPO)n(PEO)m, which has been proven to have extremely low toxicity and
immunogenic response and is widely used in many biotechnological applications [167]. In this
approach, the PDMS microchannels were filled with Pluronic F108 surfactant solution and
allowed to incubate for at least 1 hour. The concentration of Pluronic F108 solution used was 1%
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weight in water, prepared by mixing 1 g of Pluronic F108 in 100 mL of DI water. This surface
modification reduced the hydrophobic forces and enhanced the fluid movement through the
microchannels. The surface modification also reduced the formation of air bubbles within the
microfluidic channels. The surface modification lasted for a few days when compared to oxygen
plasma treatment method with a lifetime of only 3 hrs.
4.2

Micropump Performance Testing

The control system for operating the micropump consists of a mini air compressor (BTC-IIS,
part# D730A-23-01, Hargraves, Mooresville, NC) to supply compressed air and a 3-port ultraminiature solenoid valve (S070C-5BG-32, SMC Pneumatics, Noblesville, IN) to control the
supply of compressed air. Figure 4.1 shows the mini air compressor and 3-port ultra-miniature
solenoid valves used. A pressure regulator with a gauge was used to regulate the compressed air
supply to the micropump. The mini air compressor is 3 x 3 x 1 in size and weighs only 170
grams. The ultra-miniature solenoid valve is 7 x 30 x 11 mm in size and weighs only 5 g. Both
the mini air compressor and the solenoid valve are compact, lightweight and these are desirable
characteristics for portable devices. A DC power supply was used to power the mini air
compressor with a voltage of 24 V DC. A function generator (HP 3325B) was used to power the
solenoid valve with a square wave form AC signal of 12 V peak to peak with 6V DC offset. The
outlet of the micropump was connected to tubing with 1/8” ID. Figure 4.2 shows a schematic of
the experimental setup layout for micropump performance testing.
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(a)

(b)

Figure 4.1 (a) 3-port ultra-miniature solenoid valve (SMC part# S070C-5BG-32) (b) Mini Air
Compressor (Hargraves part# D730A-23-01)

Figure 4.2 Schematic of experimental setup layout for micropump performance testing
The two main control parameters that affect the performance of the micropump are the pressure
of the compressed air and the actuation frequency of the solenoid valve. The micropumps were
tested with three compressed air pressures, 10, 20 and 30 psi. For each pressure, the frequency of
operation of the solenoid valve was varied and six frequencies were used, namely, 5, 10, 15, 20,
25 and 30 Hz. Figure 4.3 shows the experimental setup on an optical table for micropump
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performance testing. Figure 4.4 shows the test fixture with various components. Figure 4.5
shows the various tubing connections on the 3-port solenoid valve. The microfluidic channel of
the micropump was first treated with Pluronic F108 solution for 2 hrs. The micropump was then
primed with DI water and the initial position of the water front in the outlet tubing was noted on
the ruler placed next to the tubing. Figure 4.6 shows the micropump clamped on the test fixture.
The micropump was operated for 3 minutes and the final position of the water front within the
outlet tubing was noted on a ruler. Figure 4.7 shows the initial and final positions of the DI water
front (shown with a green dye for better visibility). The change in position of the water front
within the tubing (ΔL) was used to compute the volume of the fluid displaced (ΔL x crosssectional area of tube based on inner diameter) by the micropump. All three micropump designs
were tested using this method.

DC Power Supply
Test Fixture

Function Generator

Figure 4.3 Experimental setup for micropump performance testing
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Mini air compressor

Pressure regulator
with gauge

Figure 4.4 Test fixture for micropump testing with various components

Pressure source
To atmosphere

To micropump

Figure 4.5 3-port solenoid valve with tubing connected to pressure source and micropump
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Ruler

Device clamp

Micropump inlet

Micropump oultet
Figure 4.6 A micropump clamped on the test fixture

Figure 4.7 (a) Initial position of DI water front (b) Final position of DI water front
4.3

Micromixer Performance Testing

The experimental setup layout for micromixer performance testing is very similar to that of the
micropump. The micromixer fluidic layer has two inlets to the mixing chamber and one outlet
for collecting the mixed sample. Three micromixer designs were tested and the performances of
the micromixers are investigated with respect to actuation frequency of the solenoid valve and
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sample flow rate. Figure 4.8 shows a schematic of the experimental setup layout for micromixer
performance testing. Figure 4.9 shows the experimental set up on an optical table for micromixer
performance testing.

Figure 4.8 Schematic of an experimental setup layout for micromixer performance testing
DC power supply
Test fixture
Syringe pump

Function generator
Figure 4.9 Experimental setup for micromixer performance testing
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Figure 4.10 shows a test fixture with various components. Figure 4.11 shows a micromixer
clamped on the test fixture.

Figure 4.10 Test fixture with various components

Figure 4.11 Micromixer clamped on the test fixture
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4.3.1 Materials
Streptavidin-biotin conjugation reactions were used to characterize the mixers’ performance and
also test the fully integrated microfluidic system. BCF microbeads (Catalog# 24173-1,
Fluoresbrite® Yellow Green fluorescent 2.0 μm diameter, 2.41×109 beads/mL) were purchased
from Polysciences, Inc (Warrington, PA). The fluorescent yellow green BCF beads have an
excitation maximum wavelength of 441 nm and an emission maximum wavelength of 486 nm,
similar to FITC. SCP microbeads (Dynabeads® M-270 Streptavidin, 2.8 μm diameter, 6.7×108
beads/mL, Catalog# 653-05) were purchased from Life Technologies (Grand Island, NY)
4.3.2 Sample Preparation
A 150 µl sample of BCF microbeads was dispensed into a microcentrifuge tube and centrifuged
at 10,000G for 5 min in a table top centrifuge. The supernatant was then removed and discarded.
The BCF microbeads were resuspended in phosphate buffered saline (PBS) with pH 7.4. This
step was repeated three times to wash the BCF beads. After the last wash, a 1.5 mL BCF sample
was prepared by mixing 150 µL of BCF beads with 1350 µL of PBS buffer. At this dilution, the
number of BCF microbeads was calculated to be 2.4×108 microbeads/mL. A 100 µL of SCP
microbeads was mixed with 1400 µL of PBS in a microcentrifuge tube and placed in a magnetic
separation stand (MagneSphere®, Promega Corp., Madison, WI) for 2 minutes. After 2 minutes
the supernatant was aspirated with a pipette while the microcentrifuge tube was still held in the
magnetic separation stand. The microcentrifuge tube was then removed from the magnetic
separation stand and 1500 µL of PBS buffer was added along the inside of the microcentrifuge
tube where the microbeads are collected. The washing procedure was repeated three times. At
this dilution, the number of SCP beads was calculated to be 4.5×107 microbeads/mL.
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Streptavidin is a tetramer with four binding sites. The ratio of BCF microbeads to SCP
microbeads is 5.4 and this ensures that the SCP microbead binding sites for biotin are saturated.
4.3.3 Micromixer and Table Top Mixer Comparison
The effect of mixing on streptavidin-biotin conjugation reaction was studied using both a table
top mixer (Thermomixer®R, Eppendorf, NY) and a Design1 micromixer. For table top mixer, a
30 μL BCF microbead sample was added to a 30 μl SCP microbead sample in a centrifuge tube.
The centrifuge tube was then mounted on the table top mixer and the sample was mixed for 15
min at 600 rpm. For micromixers, a syringe pump (PHD 2000 Programmable, Harvard
Apparatus, MA) was used to continuously inject the BCF microbeads and SCP microbead
samples into their respective inlets in the micromixer. The flow rate was 1 μL/min and the
solenoid valve was actuated at a frequency of 10 Hz. A 20 μL mixed sample from the
micromixer outlet was collected in a centrifuge tube for fluorescence measurement.
4.3.4 Performance Testing
For the frequency test, the flow rate of the samples was held constant at 2 μL/min, while the
fluorescence measurements were made for various solenoid actuation frequencies in the range of
5 to 15 Hz. For the flow rate test, the solenoid actuation frequency was held constant at 10 Hz,
while the sample flow rates were varied in the range of 1.2 - 4.0 μL/min. The BCF microbeads
and SCP microbead samples were injected simultaneously into the micromixer using a syringe
pump and the mixed sample was collected at the outlet for fluorescence measurements.
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4.3.5 Fluorescence Measurements
A VersaFluor benchtop Fluorometer (BIO-RAD Hercules, CA) was used for all fluorescence
measurements. Figure 4.12 shows the VersaFluor fluorometer and the interior section with
microcuvette and excitation and emission filters. The excitation and emission filters used in the
fluorometer were EX 490/10 nm and EM 520/10 nm respectively. The fluorometer was turned
ON for 30 min before any measurements were made.

Figure 4.12 (a) VersaFluor Fluorometer (b) a microcuvette with test sample inserted in the
cuvette holder and also shown are the excitation and emission filters

A 20 μL BCF microbead sample was diluted with 200 μL PBS buffer in a microcuvette and
labeled as the pre-coupling BCF microbead sample. The microcuvette was placed in the
fluorometer and fluorescence signal was recorded. The BCF-SCP conjugated microbeads
solution was transferred to a microcuvette and labeled as the post-coupling sample. The
microcuvette was inserted into the microcuvette holder of the fluorometer to measure the
fluorescence signal intensity of the sample in RFU. Because of the magnetic separation, only
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those BCF beads which bonded with the SCP beads remain to give off a fluorescence signal.
The concentration of the fluorescent beads is directly proportional to the intensity of the
fluorescence signal. The pre-coupling RFU values were compared with the post-coupling RFU
values to estimate the coupling efficiency. Therefore, the fluorometer reading in RFU is a good
indicator of the binding efficiency of the biotin-streptavidin beads conjugation reaction.
4.4

Integrated System of Micromixer and Micropump

The integrated micropump-micromixer system was first treated with Pluronic solution for 2
hours. The performance of the micropump was characterized by a method as described in the
previous section. Figure 4.13 shows a schematic of the experimental setup layout for testing the
integrated micropump-micromixer system for streptavidin-biotin conjugation reactions. Figure
4.14 shows the experimental setup on an optical table for testing integrated micropumpmicromixer. integrated micropump-micromixer clamped on a test fixture. The two solenoid
valves were separately controlled using individual function generators. Figure 4.15 (a) shows the
test fixture with various components. Figure 4.15 (b) shows an integrated micropumpmicromixer system clamped on the test fixture. The test samples for BCF and SCP microbeads
were prepared as described in the previous section. The BCF and SCP microbead samples were
introduced into their respective inlets with the micropump and micromixer in operation. A 20 µL
sample collected from the outlet was transferred via a pipette to a 100 µL PBS buffer in a
centrifuge tube. The centrifuge tube was then placed in a magnetic separation stand for 2 min.
After 2 min, the supernatant was aspirated and discarded while the centrifuge tube was still in the
magnetic separation stand. The centrifuge tube was removed from the magnetic separation stand
and 100 µL of PBS was added along the insides of the centrifuge tube where the separate
microbeads are collected. This washing step was repeated three times. After the washing step,
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BCF-SCP microbead conjugates were resuspended in 200 µL of PBS for fluorescence
measurements. The micromixer mixing performance based on streptavidin-biotin conjugation
reaction was tested with respect to solenoid actuation frequency, compressed air pressure and
flow rate of the samples.

Figure 4.13 Schematic of an experimental setup for integrated micropump-micromixer testing
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Figure 4.14 Experimental setup on an optical table for micropump-micromixer testing

Figure 4.15 (a) A test fixture for integrated micropump-micromixer testing (b) An integrated
micropump-micromixer clamped on the test fixture
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4.5

Impedance Spectrum Measurement

Impedance spectrum measurements were performed using a HP 4192A LF impedance analyzer.
For all impedance measurements, a sine modulated AC potential of 100 mV was applied across
the interdigitated electrodes and the magnitude and phase angle of impedance were recorded for
a frequency sweep from 10 Hz to 10 MHz. The impedance analyzer was controlled using a
labVIEW program (LabVIEW 8.0) installed on a laptop and interfaced with the impedance
analyzer via a GPIB connection. A labVIEW plug and play instrument driver for HP4192A was
downloaded from National Instruments website and modified to perform a log sweep. The
downloaded driver was originally designed for performing a linear scan. In order to perform a
log scan, the block diagrams of “HP4192A Example.vi” and “Measure.vi” components of the
downloaded driver was modified. The screenshots of the block diagram of the modified VI’s are
shown in Figure 4.16 and Figure 4.17 respectively. The data acquired from the impedance
analyzer was stored in an excel file format for further processing.

Figure 4.16 Modified block diagram of Example.vi
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Figure 4.17 Modified block diagram of Measure.vi
4.6

Magnetic Microbead Separation

4.6.1 Magnet Selection
Two approaches for magnetic separation of paramagnetic beads were studied. The first approach
was to use an electromagnet. Electromagnets of three different sizes and magnetic strength were
purchased from Rochester Magnet Co. (East Rochester, NY). The second approach was to use
permanent magnets. Neodymium disc permanent magnets of three different sizes and magnetic
strength were purchased from Rochester Magnet Co. Table 4.1 and Table 4.2 show the list of
permanent magnets and electromagnets respectively with their dimensions and magnetic field
strength ratings. Figure 4.18 shows the various electromagnets and permanent magnets listed in
Table 4.1 and Table 4.2
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Figure 4.18 (a) to (c) Permanent magnets (d) to (f) Electromagnets for magnetic separation of
SCP beads

Magnet

Diameter × Thickness (in)

PM1
PM2
PM3

0.190 x 0.125
0.220 x 0.100
0.500 X 0.060

Magnetic Field
Strength (mT)
480
400
140

Table 4.1 Specification of permanent magnets
Magnet

Diameter × Height (in)

EM1
EM2
EM3

1.25 x 1.25
1 x 1.25
0.500 x 1.5

Magnetic Field
Strength (mT)
70
120
80

Table 4.2 Specification of electromagnets
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4.6.2 Magnetic Separation Testing
Figure 4.19 shows a schematic of the experimental setup used to test the magnetic separation of
SCP microbeads. The microfluidic system was mounted on the test fixture and the magnet to be
tested was positioned below in contact with the microfluidic system. A syringe pump was used to
inject SCP beads sample at a steady flow rate and was collected at the outlet for inspection.
Figure 4.20 shows the experimental setup on an optical table for testing the magnetic separation
of SCP microbeads using an electromagnet. The flow rate of the SCP bead sample was varied in
the range of 1 - 20 µL/min. A CCD camera mounted on the microscope was used to capture the
video of SCP microbeads captured within the microfluidic system. Figure 4.21 (a) shows the test
fixture with an electromagnet placed on a lab jack and in contact with the microfluidic system
and Figure 4.21 (b) shows the the top view of the electromagnet in contact with the device. In
case of electromagnets, a 12 V DC voltage was applied to activate the microfluidic system. The
applied DC voltage was varied in the range 3 – 12 V to obtain different magnetic field strength
from the electromagnet. Figure 4.22 (a) and (b) shows the experimental set up used for testing
the permanent magnets and the top view of the microfluidic system with permanent magnet
positioned on top.
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Figure 4.19 Schematic of a setup for testing magnets for magnetic separation of SCP beads

Figure 4.20 Experimental test setup on an optical table for magnetic separation of SCP
microbeads using an electromagnet
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Figure 4.21 (a) Close view of the text fixture showing the electromagnet placed on a lab jack and
in contact with the microfluidic device (b) Top view showing the electromagnet in contact with
the device

Figure 4.22 (a) Test setup for magnetic separation of SCP beads with a permanent magnet (b)
Top view of the device with a permanent magnet positioned on top
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4.7

Fully Integrated System Testing

The fully integrated system was first tested for impedance detection for various BCF microbead
concentrations. The fully integrated system was then tested for detecting insulin based on a bead
based immunoassay to separate insulin from a test sample followed by impedance detection.
Figure 4.23 shows the schematic of an experimental setup for testing a fully integrated system.

Figure 4.23 Schematic of an experimental setup layout for testing a fully integrated device
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Figure 4.24 shows an experimental setup on an optical table for fully integrated system testing.
Figure 4.25 shows the test fixture with various components and Figure 4.26 shows the fully
integrated system clamped on a test fixture.

Figure 4.24 Experimental test setup for fully integrated microfluidic system

Figure 4.25 Test fixture with various components for fully integrated system testing
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Figure 4.26 Fully integrated microfluidic system clamped on the test fixture
4.8

BCF Microbeads Detection

The fully integrated microfluidic system was treated with Pluronic solution to make the PDMS
surface hydrophilic and also reduced any non-specific protein binding. Figure 4.27 shows the
process flow for testing streptavidin-biotin conjugation followed by impedance measurement of
BCF microbeads. The micropump was operated at a flow rate of 2 μL/min and the micromixer
was operated at 10 Hz, 20 psi conditions. A 20 μL sample of BCF microbead solution and 20 μL
of SCP microbead solution were introduced in their respective inlets and pumped to the mixing
chamber. A permanent magnet placed below the IDE was used to attract the SCP microbeads and
hold them close to the surface of the electrodes. A 20 μL solution of MES buffer was introduced
at the inlet and a flow rate of 10 μL/min was used to wash away any unbound BCF microbeads
within the mixing chamber. The wash step was repeated twice. After the wash step, impedance
measurement was performed by following a procedure as described in the impedance
measurement section.
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Figure 4.27 Process flow for BCF microbead detection using the fully integrated microfluidic
system
4.9

Insulin Detection

4.9.1 Preparation of Magnetic Beads-Antibody Conjugate (MBAC)
A protein coupling kit (BioMag® Plus Carboxyl Protein coupling starter kit, Catalog# 86010-1)
was purchased from Polysciences, Inc. (Warrington, PA). The kit includes magnetic microbeads
(BioMag® Plus Carboxyl terminated particles, 2.5 mL, 20 mg/mL, Catalog# 860111-10)
functionalized with carboxyl group, 0.1 g of EDC (1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide), 15 mL conical centrifuge tubes, a magnetic separator (MultiStep® Biomag
separator), 25 mL quenching solution, 175 mL MES buffer (pH 5.2, 0.05 M) and 125 mL wash
buffer. Unconjugated Mouse Anti-Insulin (1G11) monoclonal antibody (MAI-Ab) (Catalog#
bsm-0855mm, 100 µg lyophilized) was obtained from Bioss , Inc. (Woburn, MA). The carboxyl
groups on the surface of the microbeads are first activated by carbodiimide which allows the
amine groups on antibodies to be covalently attached.
4.9.2 Activation of Carboxyl Groups
A 0.5 ml (10.0 mg) sample of magnetic microbeads was transferred to a 15 mL conical
centrifuge tube. The centrifuge tube was inserted into the magnetic separator stand for 3 min to
allow magnetic separation. The supernatant was then aspirated and discarded. The centrifuge
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tube was removed from the magnetic separator and a 5 mL MES buffer solution was added. The
centrifuge tube was then vigorously shaken to mix. The centrifuge tube was inserted into the
magnetic separator for 3 min to allow magnetic separation. The supernatant was then aspirated
and discarded. The washing step with MES buffer was repeated three times. After the final wash
the magnetic beads were resuspended in 5 ml of MES buffer. The EDC was removed from the
freezer and allowed to thaw for a minimum of 30 min. The required mass of EDC (1.6 mg
EDC/mg of magnetic beads) was measured, added to the magnetic beads in solution and mixed
vigorously on a table top shaker for 30 s. The centrifuge tube was then placed in a shaker (Orbit
Environ-Shaker model 3527, Lab-Line) at 250 rpm for 30 min at room temperature. It is
important to not allow the beads to settle during mixing. After mixing the activated magnetic
beads were magnetically separated on the magnetic separator and the supernatant was aspirated
and discarded. After the magnetic separation 5 mL of MES buffer was added to the activated
magnetic beads and shaken on a table top shaker (Touch Mixer model 232, Fisher Scientific,
Pittsburgh, PA) for 30 s. The activated magnetic beads were magnetically separated on the
magnetic separator, supernatant was aspirated and discarded. This wash step with MES buffer
was repeated three times.
4.9.3 Antibody Coupling
A 100 µg sample of MAI-Ab in the lyophilized form was reconstituted with 100 µL sterile DI
water to obtain a stock concentration of 1 µg/ µL. A 100 µL sample of MAI-Ab solution was
diluted with 0.5 mL MES buffer. A 50 µl sample of diluted MAI-Ab solution was removed and
added to 950 µL of MES buffer to obtain a 1:20 dilution “pre-coupling sample” for coupling
efficiency determination. The remaining MAI-Ab was added to the activated magnetic beads
and mixed in a shaker (Orbit environ-shaker model 3527, Lab-line) at 250 rpm for 24 hrs at room
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temperature to obtain MBAC. After coupling, the MBAC were magnetically separated on a
magnetic separator. The supernatant was aspirated and saved as the “post-coupling sample” for
coupling efficiency determination. The MBAC were resuspended in 0.5 mL MES buffer and
mixed using a table top shaker (Touch Mixer odel 232, Fisher Scientific, Pittsburgh, PA). After
mixing the MBAC were magnetically separated and the supernatant was aspirated and discarded.
A 0.5 mL quenching solution was added to the MBAC and mixed in a shaker at room
temperature for 30 min. After mixing, the MBAC was magnetically separated and the
supernatant was aspirated and discarded. A 0.5 mL wash buffer was added to the MBAC and
mixed on a table top shaker. After mixing, the MBAC was magnetically separated and the
supernatant was aspirated and discarded. This wash step was repeated three times. After the last
wash, the MBAC were resuspended to 0.2 mL in wash buffer. The MBAC were stored at 4°C as
a suspension in wash buffer.
4.9.4 Coupling Efficiency Determination
In order to determine the coupling efficiency of MAI-Ab and magnetic microbeads, a QuantiT™ Protein Assay kit (Life Technologies, Carlsbad, CA) was used. The kit included a protein
reagent (component A), eight BSA standards of known concentrations (component B) and a
protein buffer solution (component C). A protein working solution was prepared by diluting 30
μL of protein reagent in 5970 μL protein buffer solution to obtain a 1:200 dilution. A 10 μL
sample of each BSA standard was added to 190 μL of protein buffer solution in a separated
centrifuge tube to obtain BSA standard test solution and labeled with respective standard
number. This sample preparation step was performed three times to obtain triplicates of each
BSA standard test solution and protein working solution. All of the centrifuge tubes with BSA
standard test solution were shaken on a table top shaker for 3 seconds and then incubated at room
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temperature for 15 min. After 15 min of incubation, 200 μL of the BSA standard test solution
were transferred to a microcuvette to perform fluorescence measurements using the Fluorometer.
This step was performed to obtain three fluorescence readings for each of the eight BSA standard
test solution. The fluorescence reading of the BSA standard solutions was plotted against their
respective known concentrations to obtain a standard calibration curve. A 20 μL solution of the
“pre-coupling sample” was mixed with 180 μL of protein working solution in a centrifuge tube
to obtain a pre-coupling test solution. This step was repeated three times to obtain a triplicate of
the pre-coupling test sample. A 20 μL solution of the “post-coupling sample” was mixed with
180 μL of protein working solution in a centrifuge tube to obtain a post-coupling test sample.
This step was repeated three times to obtain a triplicate of the post-coupling test sample All of
the centrifuge tubes were shaken on a table top shaker for 3 seconds and then the samples were
incubated at room temperature for 15 min. After 15 min of incubation, 200 μL of each sample
was transferred to a microcuvette to perform fluorescence measurements using the Fluorometer.
The coupling efficiency was calculated based on the RFU values of the”pre-coupling sample”
and “post-coupling sample”.
4.9.5 Insulin Detection
A 1 M, 100 mL solution of 2-Morpholinoethanesulphonic acid (MES) was purchased from
Sigma-Aldrich (St. Louis, MO) and was diluted with DI water to obtain a 100 mM MES
solution. Insulin, Recombinant Human (Catalog# 91077C-100MG) was purchased from SigmaAldrich (St. Louis, MO). A 1 L standard solution of 0.1M Hydrochloric Acid (HCl) (Catalog#
38280-1EA) was purchased from Sigma-Aldrich (St. Louis, MO) and diluted with DI water to
obtain a 0. 01 M HCl solution. A 10 mg sample of insulin was mixed in a 20 ml solution of 0.01
M HCl in a centrifuge tube to obtain an insulin stock solution. The stock solution was serially
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diluted with MES buffer solution to obtain insulin samples of concentrations ranging from 10 -11
to 10-5 M. The concentration of insulin antibody was calculated based on the coupling efficiency
of MAI-Ab and magnetic microbeads. For MAI-Ab, with molecular weight 160 kDa, and a mass
of 100 µg, with 85% coupling efficiency:

Concentration of insulin antibody

(

)

(

)

(4.1)

For a 20 μL insulin sample with a concentration of 10-5 mol:
Concentration of insulin

(

(4.2)

)

The concentration of insulin antibodies used was 2.65 times more than the highest insulin
concentration that was tested. Figure 4.28 shows the process flow for insulin detection.

Figure 4.28 Process flow for insulin detection using the fully integrated microfluidic system
The fully integrated device was first treated with Pluronic solution for 2 hours to make the
PDMS surface hydrophilic and also reduced any non-specific protein binding. The micropump
was operated at a flow rate of 2 μL/min and the micromixer was operated at 10 Hz, 20 psi
conditions. A 20 μL sample of MBAC and 20 μL of insulin sample were introduced
simultaneously in their respective inlets and pumped to the mixing chamber. A permanent
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magnet placed below the IDE was used to attract the MBAC and hold them close to the surface
of the electrodes. A 20 μL solution of MES introduced at the inlet and a flow rate of 10 μL/min
was used to wash away any unbound insulin within the mixing chamber. The wash step was
repeated twice. After the wash step, impedance measurement was made by following a
procedure as described in the impedance measurement section.
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5. RESULTS AND DISCUSSIONS
This chapter presents and analyzes the experimental results and numerical simulation. The first
section presents the results of the performance testing for the three pump designs. Specifically,
the variation of flow rate with respect to actuation frequency and compressed air pressure is
analyzed. The experimental results are compared with the results of a 2D COMSOL simulation
of the micropump. The second section discusses the qualitative and quantitative performance of
the micromixer. The qualitative testing was based on mixing of two colored dyes with respect to
time. The quantitative testing was based on mixing efficiency determination for biotinstreptavidin bead conjugation reaction with respect to actuation frequency, flow rate and
compressed air pressure. The third section discusses the magnetic microbead separation scheme
using permanent magnets and electromagnets of various sizes and magnetic strengths. The fourth
section discusses the testing of the integrated microfluidic system for detection of biotin coated
beads and insulin.
5.1

Performance of Micropumps

The performance characteristics of the three micropump designs were experimentally
determined. The two main control parameters that affect the performance of the micropump are
the compressed air pressure and the actuation frequency of the solenoid valve.
5.1.1 Repeatability of Flow Rate
For each design, the variation of flow rate within an individual micropump when tested three
times and variation of flow rates between three separate micropumps was determined. Figure 5.1
shows the variation in average flow rate within a single Design1 micropump when tested three
times. Figure 5.2 shows the variation in average flow rate between three micropumps of
108

Design1, each tested three times. The mean variation in flow rate for a micropump of Design 1
was 4.6%, with a maximum variation of 6.5% and a minimum variation of 1.54%. The mean
variation in flow rates between three micropumps of Design1 was determined to be 8.25%, with
a maximum variation of 19.7% and a minimum variation of 1.3%.

Figure 5.1 Flow rate variations within a single Design1 micropump

Figure 5.2 Flow rate variations between three different micropumps of Design1
109

Figure 5.3 shows the variation in average flow rate within a single Design2 micropump when
tested three times. Figure 5.4 shows the variation in average flow rate between three micropumps
of Design2, each tested three times.

Figure 5.3 Flow rate variations within a single Design2 micropump

Figure 5.4 Flow rate variations between three different micropumps of Design2
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The mean variation in flow rate for a micropump of Design2 was 2.9%, with a maximum
variation of 6.0% and a minimum variation of 0.75%. The mean variation in flow rates between
three micropumps of Design2 was determined to be 10.6%, with a maximum variation of 17.4%
and a minimum variation of 1.75%. Figure 5.5 shows the variation in average flow rate within a
single Design3 micropump when tested three times. Figure 5.6 shows the variation in average
flow rate between three micropumps of Design3, each tested three times. The mean variation in
flow rate for a micropump of Design3 was 1.9%, with a maximum variation of 5.4% and a
minimum variation of 0.8%. The mean variation in flow rates between three micropumps of
Design3 was determined to be 10.3%, with a maximum variation of 17.3% and a minimum
variation of 1.57%.

Figure 5.5 Flow rate variations within a single Design3 micropump
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Figure 5.6 Flow rate variations between three different micropumps of Design3
The variation in flow rates from one pump to another of the same design can also be attributed to
variations in the thickness of the PDMS membrane between micropumps. The variation in
thickness of the PDMS membrane is due to the non-uniformity of the SU-8 film thickness
obtained by the spin coating process step in fabrication of the SU-8 mold used for casting
PDMS. A DekTak profilometer measurement indicated that the SU-8 film thickness varied
between 90 – 100 µm at different locations on the wafer.
After the completion of the micropump performance testing for all three designs, Design 3 was
selected to be incorporated into the fully integrated microfluidic system. Among the three
micropump designs, Design 3 was observed to have the highest flow rate (16 µL/min at 20 Hz,
30 psi operating conditions) with the lowest mean variation in flow rate. The fabrication yield
with Design 3 was also observed to be higher than other designs. The circular air chamber
geometry used in Design3 provides an advantage over the rectangular air chamber geometry with
sharp corners used in Design1 and Design2. The circular geometry of Design 3 air chambers
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enables an easier release of the cured PDMS without any tear while being removed from the SU8 mold during the fabrication process. In case of Design1 and Design2, the cured PDMS tends to
tear at the corners causing a reduction in the yield per wafer.
5.1.2 Peak Flow Rate
The micropump performance test results indicate that at a constant pressure, the flow rate
increases with an increase in actuation frequency until a peak flow rate is reached and is
followed by a drop in flow rate at higher frequencies. The frequency at which the peak flow rate
is observed is referred to as the optimal frequency. The average peak flow rates observed with
Design1, Design2 and Design3 micropumps are 12.75 µL/min (at 30 psi, 15 Hz), 10.75 µL/min
(at 30 psi, 15 Hz) and16.0 µL/min (at 30 psi, 20 Hz) respectively. The maximum flow rate at a
constant pressure depends on the fill and release time of the compressed air within the air
chambers. The actuation frequency used to cycle the compressed air pressure controls the time
available for the pressure inside the air chambers to change with time. If the frequency of
operation is too high, there is not enough time for the air chambers to be completely filled and
released and the flow rate decreases. If the operation frequency is too low, the number of pump
cycles would also be low with idle time in between cycles, leading to lower flow rates even
though the air chambers would have enough time to reach the actuation pressure. It was observed
that the peak flow rate for the various designs increased with pressure. For Design3, the peak
flow rate increased by 30% when the pressure was increased from 10 psi to 20 psi. The
deflection of a PDMS membrane is directly proportional to the applied pressure. As the applied
pressure is increased the deflection of the PDMS membrane increases and causes more fluid
volume to be displaced, resulting in an increased flow rate.
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These results of flow rate variation with respect to actuation frequency, with a peak flow rate at
an optimal frequency, are similar to some of the previously reported peristaltic micropumps. A
peristaltic micropump with piezoelectric actuation [168] has been reported to have a similar flow
rate dependency on frequency. The flow rate was observed to increase with frequency until a
peak flow rate of 25 µL/min was attained at an optimal frequency of 200 Hz, followed by a drop
in flow rates for all higher frequencies. Similarly, a single stroke peristaltic PDMS micropump
has been reported [169] with the flow rate increasing with frequency until a peak flow rate of 4
µL/min was observed at an optimal frequency of 15 Hz, followed by a drop in flow rate for all
higher frequencies. The micropumps were tested over a period of three months without any
failure. The durability of the micropump would mainly depend on the fracture of the PDMS
membranes. However, PDMS is a highly resilient polymer material [170] and the performance of
the micropump is satisfactory as long as the operating conditions are well regulated.
5.2

Micropump Simulation - Equivalent Circuit Analysis

In order to better explain the results of the micropump performance with the existence of a peak
flow rate, an equivalent circuit simulation and COMSOL simulation was carried out. The
purpose of the equivalent circuit analysis is to determine the time delay between the sequential
actuation of the four PDMS membranes. The micropump system was converted into an
equivalent electrical circuit and then analyzed using the SPICE analog circuit simulation
software.
The equation governing a mechanical system [171] can be written as
∫

(5.1)
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where F, υ, m, α and k are the force, velocity, mass, friction coefficient and stiffness
respectively.
Equation 5.1 can be rewritten [171] as
( )

( )

( )∫

(5.2)

where P, ϕ and S are the pressure, flow rate and area normal to flow direction respectively.
Equation 5.2 is similar to a series RLC circuit with an equation [171] as below
∫

(5.3)

where e, L, i, R, C are voltage, inductance, current, resistance and capacitance respectively.
Comparing equations 5.2 and 5.3, an analogy between fluidic system and an electrical system
can be obtained as shown in Table 5.1 [171]

Mechanical/Fluidic Parameters
Φ
flow rate
P
pressure
m/S2 (where m is mass)
α/S2 (where α is friction coefficient)
k/S2 (where k is the stiffness)

Equivalent Electrical Parameters
i
Current
e
Voltage
L
Inductance
R
Resistance
C
Capacitance

Table 5.1 Mechanical/Fluidic parameters and their electrical analogues.
Hydraulic resistance (Rhyd) represents energy dissipation due to fluid’s viscous friction against
component’s wall and is calculated by integrating the velocity profile over the cross-sectional
area of the channel such that flow rate as a function of pressure drop is known [172]. Hydraulic
resistance depends on the channel geometry. For a channel with rectangular cross-section, Rhyd is
calculated as [172]
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(

(

))

(5.4)

where l is channel length, a is half channel width, b is half channel height and µ is fluid
viscosity. The hydraulic capacitance (Chyd) represents the elastic behavior of the microfluidic
component and relates the pressure difference to volume variation [173]. This variation is due to
both the deformation of the structure and the elastic property of the fluid [173]. Chyd for a
polymer membrane is given by
(

)

(5.5)

where a is the side length of the membrane, S is the shape factor,

is the Poisson’s ratio, t is the

membrane thickness, and E is the Young’s modulus of the membrane. A compressed air source
applying pressure on the PDMS membrane is equivalent to applying a voltage to a node on the
equivalent circuit. The compressed air pressure can be represented by a voltage source in the
equivalent circuit.
5.2.1 Transient Response of the Equivalent Circuit
The time-phased sequential deflection of the PDMS membranes with interconnecting
microchannels when actuated by a single compressed air source can be modeled by a parallel RC
circuit. The RC circuit can be modeled by replacing the chambers and the membranes with
electrical capacitors (C1, C2, C3 and C4) and the interconnecting microchannels with the
electrical resistors (R1, R2, R3 and R4). The compressed air source connected to the inlet of the
air chambers through a solenoid valve controlled by square wave voltage signal can be replaced
by a square pulse voltage source Vin. Table 5.2 shows the calculated values of resistances and the
capacitances for all components of the equivalent circuit as shown in Figure 5.7.
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Resistor
R1
R2
R3
R4

Value ( Nsm-5)
3.4 x 1010
1.5 x 1010
9.0 x 109
9.0 x 109

Capacitor
C1
C2
C3
C4

Value ( m5N-1)
1.4 x 10-14
5.0 x 10-14
5.0 x 10-14
5.0 x 10-14

Table 5.2 Equivalent circuit component values for Design 3

Figure 5.7 Equivalent circuit representation of a micropump with four PDMS membranes
Each of the four air chambers of the micropump have a different time constant because of the
pressure loss of the compressed air along the interconnecting microchannel and the deflection of
the membranes. According to the equivalent circuit analogy described in the previous sections,
the PSPICE solution for voltage across each capacitor in the equivalent circuit is analogous to
the actual pressure inside the corresponding air chamber. The results of the PSPICE transient
response analysis of the equivalent circuit for 10 psi, 20 Hz operating conditions is shown in
Figure 5.8. The plot is normalized against the source voltage and the period of the cycle. The
first half of the plot (from t=0 to t=0.025 s) represents the charging of the capacitor (analogous to
air pressure increasing within air chamber) and the second half of the plot represents the
discharging of the capacitor (analogous to air pressure reducing within the air chamber). During
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the first half of the plot (upstroke), the air pressure within each chamber rises from atmospheric
pressure and gradually approaches the source pressure. It can be seen from the upstroke pressure
curves that the air chambers fill up in a sequence, air chamber 1 filling up first, followed by air
chambers 2, 3 and 4, leading to a peristaltic motion. At one time constant, which is the time
taken by the capacitor to charge to 63% of its fully charged voltage, the time delay between the
first, second and third air chambers is 3 ms, 1ms and 1ms respectively. The deflection of the
PDMS membrane is directly proportional to the pressure inside the chamber and therefore the
deflection curves for the membraness would have a similar trend as the pressure curves. Since
the Chamber 1 has a much higher time constant than the rest of the chambers, the membrane in
the Chamber 1 would deflect first and therefore also function as a valve that reduces any
backflow. During the second half of the plot (downstroke), the pressure within the air chamber
gradually drops from the source pressure to the atmospheric pressure. It can be seen from the
downstroke pressure curves that the air chambers empty in a sequence.

Figure 5.8 PSPICE transient response of the equivalent circuit
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5.3

Micropump Simulation - COMSOL

The time delay obtained from the equivalent circuit simulation was used in performing a
COMSOL simulation to verify the flow rate trend of the micropump. A 2D finite element
simulation of the micropump was performed using the MEMS module of COMSOL
MulitphysicsTM. The MEMS module includes a fluid-structure interaction (FSI) interface. The
FSI interface couples fluid flow and solid mechanics using arbitrary Lagrangian-Eulerian (ALE)
method to study the interaction between the fluid and the solid structure.
The fluid flow is described by the Navier Stokes equations to solve for velocity field, u = (u, v),
and the pressure p, in the spatial (deformed) moving coordinate system:
[

(

(

) )]

)

((

)

(5.6)
(5.7)

In the above equations, I represents the unit diagonal matrix. The Navier Stokes equations are
solved on a freely moving deformed mesh. The co-ordinate system velocity is

(

)

The structural deformations are solved using an elastic, non-linear geometry formulation to allow
large deformations. The total force exerted on the fluid-solid boundary is given by:
{
where

( (

(

) )}

(5.8)

is the normal vector to the boundary and

represents a sum of pressure and viscous

forces.
The 2D model of the micropump consists of three layers as shown in Figure 5.9. The lower most
layer (shown in red) represents the rigid glass layer. The top most layer consists of a combination
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of flexible PDMS membranes (M1, M2, M3 and M4 shown in blue) and rigid PDMS (shown in
grey) layer. The middle layer represents the fluidic layer (shown in green). The width and the
thickness of the four PDMS membranes were set to be 1500 µm and 100 µm respectively. The
height of the glass layer and fluidic layer were set to 100 µm. The fluidic layer was assigned the
material properties of water with density, dynamic viscosity as 1000 kg/m3 and 0.001 Ns/m2
respectively. The glass layer was assigned material properties that include Young’s modulus,
Poisson’s ratio, density equal to 72 GPa, 0.3 and 2500 kg/m3 respectively.

M1

M2

M3
Fluidic layer
Glass layer

M4

Figure 5.9 2D view of the micropump model with multiple layers
The PDMS layers were assigned material properties [174] that include Young’s modulus,
Poisson’s ratio, and density equal to 75 MPa, 0.49, and 920 kg/m3 respectively. Figure 5.10
shows a snapshot of the properties tab in COMSOL for defining material properties.

Figure 5.10 Material properties of PDMS
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The boundaries of fluid layer in contact with the PDMS and glass layers were assigned a fluidsolid interface boundary condition. The fluid layer domain was assigned a free deformation
boundary condition. The boundaries of the PDMS membrane along the y-axis were assigned a
fixed constraint. The boundaries of the rigid PDMS layers were assigned a fixed constraint. All
the parameters including time period (t), frequency (f), fluidic channel width (W), fluidic channel
height (H) and net force (F) were defined in the parameters settings under the global settings
menu. Figure 5.11 shows a snapshot of the user input parameters tab in COMSOL.

Figure 5.11 Definition of global parameters
Three square waveform functions, namely wv1, wv2, wv3 and wv4 were defined under the
definitions menu. Figure 5.12 shows a screen shot of the definition of the waveform wv1. These
square waveform functions can be invoked with angular frequency, phase and amplitude as
variable parameters. Four boundary loads, namely Boundary Load 1, Boundary Load 2,
Boundary Load 3 and Boundary Load 4 were defined on the PDMS membranes M1, M2, M3
and M4 respectively. The boundary loads were defined as time-dependent forces with total force
defined as a product of the force and the respective square waveform function. For example,
Boundary Load 1 was defined as

. The negative sign indicates that the force acts in
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the negative y direction. Figure 5.13 shows an example of boundary load definition. The mesh
settings were defined to be free triangular with a default fine element size set for fluid dynamics.

Figure 5.12 Waveform wv1 definition parameters and plot of waveform wv1

Figure 5.13 Boundary load definition
Figure 5.14 shows a close-up view of the mesh for the circled part of the model before and after
deformation. A time dependent solver with 1 ms time stepping was used to obtain the solution
for one time period. Figure 5.15 shows the change in displacement of the PDMS membrane
plotted against the arc length of the PDMS membrane for various time instances, at 10 psi, 5 Hz
operating conditions.
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(a) Before deformation

(b) After deformation
Figure 5.14 Mesh diagram of membrane M1 before and after deformation
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Figure 5.15 Membrane displacements vs. arc length of the membrane for various time instances
Figure 5.16 shows the change in displacement of all four PDMS membranes (M1, M2, M3 and
M4) plotted against the arc length of the PDMS membrane at time t=0.01s, at 10 psi, 20 Hz
operating conditions. It can be seen from the Figure 5.16 that there is a time delay between the
deflections of the membranes.

Figure 5.16 Membrane displacements vs. arc length of four membranes at t=0.01s

124

At t = 0.01s, membrane displacement of M1, M2, M3 and M4 are 1.8 µm, 2.4 µm, 1.15 µm and
0.06 µm respectively. Membrane M1 deflects first and functions as a valve to reduce the back
flow. The membranes M2, M3 and M4 have the same dimensions and are subjected to the same
compressed air pressure of 20 psi. However, they show different membrane displacements due to
the time delay between the actuation of the three membranes. This sequential deflection of the
PDMS membranes leads to peristalsis causing the fluid underneath to flow. The flow rate was
calculated in the post-processing by defining boundary integral to integrate velocity at the outlet
boundary. Figure 5.17 shows a comparison of the average experimental flow rate and simulation
flow rate obtained at 10 psi for a frequency ranging from 5 to 35 Hz.

Figure 5.17 Experimental and simulation flow rates variation with frequency
The simulation flow rate with respect to frequency has a similar trend as that of the experimental
results. The flow rate increases with frequency to reach a peak value at an optimum frequency,
followed by a drop in flow rate for all frequencies higher than the optimum frequency. It can be
observed from Figure 5.17 that in general the simulation flow rate results are higher than the
experimental results. Also, the difference in simulation and experimental flow rates depends on
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the frequency. The simulation model did not include the effects of pressure drop caused by the
microfluidic connectors and external tubing connected to the outlet of the micropumps. The
simulation model also does not include the pressure drop caused by the air bubbles generated
within the fluidic layer of the micropump. The fluidic layer of the micropump was surface
treated with Pluronic F108 which helps to reduce the generation of air bubbles but not
completely eliminate them. It was also observed during the micropump performance testing that
more air bubbles were generated at higher frequencies. This can cause a considerable pressure
drop at higher frequencies which can cause the experimental flow rates to drop significantly.
5.4

Performance of Micromixers

The performance characteristics of three micromixer designs were experimentally determined. A
qualitative test was first performed to compare the active mixing with diffusion mixing that
occurs naturally when no external mixing is performed.
5.4.1 Qualitative Testing
The performance of the mixer was qualitatively tested for mixing of two colored dyes. The time
taken for active mixing was compared with time for mixing purely by diffusion. Figure 5.18
shows the pictures of the dye mixing within the device by diffusion as time progresses. It takes 6
min for the two dyes to mix and reach one uniform color. Figure 5.19 shows the pictures of the
two dyes mixing within the device by active mixing caused by the deflecting membranes of the
micromixer as time progresses. It took only 20 s to complete the mixing process by active
mixing and mixing time is 18 times shorter than mixing by pure diffusion. These results indicate
that the designed active micromixers are effective in reducing mixing times.
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(a) t = 0 min

(b) t = 2.5 min

(c) t = 4 min

(d) t = 6 min

Figure 5.18 Diffusion only mixing at various time instants

(a) t = 2 s

(b) t = 10 s

(c) t = 15 s

(d) t = 20 s

Figure 5.19 Active mixing at various time instants

5.4.2 Comparison with Table Top Mixer
The mixing process at micro scale using the micromixer was compared with the macro scale
mixing using the table top mixer. A micromixer and a table top mixer were used to mix SCP
beads and BCF beads in order to achieve a streptavidin-biotin conjugation reaction. The relative
increase in conjugation reactions due to active mixing methods when compared to mixing by
pure diffusion alone (control) is shown in Figure 5.20 for micromixer and a table top mixer. The
intensity of fluorescence signal is a direct measure of the extent of mixing. Both micromixers
and table top mixers resulted in a significant increase in fluorescence signal. This clearly
indicates the need for active mixing on both micro and macro scale for streptavidin-bioin
conjugation reaction, and confirms that agitation of the flow improves binding efficiency. Due to
the absence of turbulence in microfluidic systems, unless some form of flow agitation by active
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mixing is present, mixing can only happen by diffusion. In case of micromixers, there was a 45%
increase in the fluorescence signal due to active mixing, whereas in case of the table top mixer,
there was only a 15% increase. These results indicate that active mixing at micro scale can
improve the mixing performance.

Figure 5.20 Increase in binding efficiency using a micromixer and table top mixer
5.4.3 Mixing Performance Variation with Frequency
Figure 5.21 shows a normalized plot of the average RFU with respect to frequency for the three
micromixer designs tested three times. The actuation frequency was varied from 5 – 20 Hz at a
constant flow rate of 2 µL/min and a compressed air pressure of 20 psi. The mean variation in
RFU with respect to average RFU for a micromixer of Design 3 was 3.3%, with a maximum
variation of 4.2% and a minimum variation of 2.56%. The mean variation in RFU for a
micromixer of Design 2 with respect to average RFU was 8.27%, with a maximum variation of
13.03% and a minimum variation of 2.87%. The mean variation in RFU with respect to average
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RFU for a micromixer of Design 1 was 12.9%, with a maximum variation of 15.3% and a
minimum variation of 9.66%. Design 3 has the best mixing performance when compared to other
designs during the frequency test. The peak RFU signal obtained for Design3 is 70% higher than
Design2. In case of Design1, there was no significant change in RFU with change in frequency.

Figure 5.21 Normalized RFU vs Frequency for three mixer designs
As the actuation frequency increases, the agitation within the mixing chamber increases and
results in an increase in the streptavidin-biotin conjugation reaction until an optimal frequency is
reached. The reduction in conjugation reaction at higher frequencies beyond the optimal
frequency can be attributed to the response time of the membrane. At higher frequencies, there is
insufficient time for the air chamber to be completely filled and exert pressure on the membrane
to actuate it.
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5.4.4 Mixing Performance Variation with Flow Rate
The mixing performance was tested three times with respect to change in flow rate for the three
micromixer designs. The flow rate range was varied from 1.2 – 4 µL/min at a constant frequency
of 10 Hz and a constant compressed air pressure of 20 psi. Figure 5.22 shows the normalized plot
of the average RFU with respect to flow rate for the three micromixer designs.

Figure 5.22 Normalized RFU vs. Frequency for individual mixer designs
It can be observed that the streptavidin-biotin conjugation reaction increases with the flow rate
until it reaches a peak value. The mean variation in RFU with respect to flow rate for a
micromixer of Design3 was 6.33%, with a maximum variation of 12.9% and a minimum
variation of 3.13%. The mean variation in RFU with respect to average RFU for a micromixer of
Design2 was 9.13%, with a maximum variation of 13.92% and a minimum variation of 4.82%.
The mean variation in RFU with respect to average RFU for a micromixer of Design1 was
10.29%, with a maximum variation of 14.29% and a minimum variation of 3.85%.
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As the flow rate increases, the microbeads’ retention time in the mixer is reduced and the
microbeads thus have less time to interact with each other, which reduces streptavidin-biotin
conjugation reaction. However, at the lowest flow rate (1.2 µL/min), which corresponds to the
largest retention time, the conjugation efficiency is the lowest. This is most likely due to the
absence of recirculating eddies which occur only at higher Reynolds numbers (Re). The
backwards flow and re-circulation of the fluid in these eddies allows more time within the
mixing chamber for the beads to interact with each other and increases flow agitation, thus
increasing streptavidin-conjugation reaction. At 1.2 µL/min, Re ~ 0.01 and the flow falls in the
range of Stokes flow which closely follows the contour of the mixing chamber without
recirculation. The recirculation phenomenon depends on the Reynolds number, and the channel
geometry is the same for all designs. Therefore, the differences in designs do not significantly
affect the flow rate at which peak mixing efficiency occurs. The highest mixing performance
was observed at 2 µL/min. Design3 has the best mixing performance with respect to flow rate.
At 2 µL/min, the peak RFU value of Design3 is 70% higher than Design2. Design1 did not show
any significant variation in performance with change in flow rate. Based on the highest
performance of Design3 with respect to both frequency and flow rate, Design3 was selected to be
incorporated into the fully integrated microfluidic system.
Despite the numerous recent works on micromixers, characterization of micromixers still
remains a challenge [175]. Micromixers are commonly characterized based on three
nondimensional fluid parameters: Re, Péclet number (Pe), and Strouhal number (St) [176].
Péclet number is a measure of the relative importance of advection and diffusion in providing the
mass transport associated with the mixing. Pe is defined as
(5.9)
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where U is the velocity of the fluid, L is the mixing path which is on the same order of the height
of the mixing chamber in this study and D is the diffusivity of the fluids. Strouhal number is
generally associated with active mixers and represents the ratio between the residence time of a
species and the time period of disturbance. St is defined as:
(5.10)
where f is the frequency of the disturbance action and Dh is the hydraulic diameter. The optimum
mixing efficiency occurs at a frequency of 10 Hz and a flow rate of 2 µL/min. The characteristic
Pe, St and Re values of the micromixer to perform at the optimum mixing efficiency conditions
were calculated to be 11.2, 17.5 and 0.02 respectively.
A magnetic particle driven micromixer design has been reported [177] with a mixing
performance dependence on driving frequency similar to the one observed in this study. The
peak mixing efficiency was observed at an optimum frequency of 20 Hz. A microfluidic
electroosmotic mixer has been reported [178] with a study on the effect of frequency on the
mixing efficiency. The performance curve for variation of mixing efficiency with frequency,
with a peak mixing efficiency at an optimum frequency of 22 Hz, is similar to the one observed
in this study.
5.5

Performance of Integrated Micromixer and Micropump

A micropump (Design3) and micromixer (Design3) were integrated on a single device to obtain
an integrated micromixer-micropump and tested for mixing efficiency based on streptavidin
biotin conjugation reaction. Mixing efficiency was calculated by comparing the RFU values of
20 μL volumes of fluorescent bead sample with the RFU value of 20 μL of the post mixing
sample after magnetic separation/washing step. Figure 5.23 (a) and (b) shows the normalized
132

plot of average RFU and mixing efficiencies for a frequency range of 5 to 25 Hz. The mean
variation in RFU with respect to average RFU is 4.08%, with a maximum variation of 5.4% and
a minimum variation of 2.4%. A maximum mixing efficiency of 83.3 % was observed at 10 Hz.

(a)

(b)

Figure 5.23 (a) Normalized RFU vs Frequency (b) Mixing efficiency vs Frequency
Figure 5.24 (a) and (b) shows the normalized plot of average RFU and mixing efficiencies for a
pressure range of 5 to 30 psi. The mean variation in RFU with respect to average RFU is 6.7%,
with a maximum variation of 10.5% and a minimum variation of 3.4%. A maximum mixing
efficiency of 82.8 % was observed at 20 psi. Figure 5.25 (a) and (b) shows the normalized plot
of average RFU and mixing efficiencies for a flow rate range of 1 to 6 μL/min. The mean
variation in RFU with respect to average RFU is 6.58%, with a maximum variation of 11.5% and
a minimum variation of 2.66%. A maximum mixing efficiency of 82.1 % was observed at 2
μL/min.
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(a)

(b)

Figure 5.24 (a) Normalized RFU vs. pressure (b) Mixing efficiency vs. pressure

(a)

(b)

Figure 5.25 (a) Normalized RFU vs. flow rate (b) Mixing efficiency vs. flow rate
Based on the performance testing results, the optimum operating conditions for obtaining the
highest mixing performance is 2 µL/min sample flow rate, 10 Hz actuation frequency and a
compressed air pressure of 20 psi. The micromixer was operated under these conditions for all
further testing.
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5.6

Magnetic Microbead Separation Scheme

The testing for magnetic microbead separation included both electromagnets and permanent
magnets of various sizes and magnetic strengths.
5.6.1 Electromagnets
Three electromagnets of different size and strength, namely EM1, EM2 and EM3 were tested. In
case of electromagnets EM1 and EM3, it was not possible to capture all the SCP beads even at a
SCP bead sample flow rate of 1 μL/min. The magnetic field strength generated by EM1 and EM3
was not sufficient enough to overcome the hydrodynamic drag force. In case of EM2, it was
possible to capture SCP beads successfully up to a bead sample flow rate of 1.5 μL/min. The
magnetic force exerted on the SCP bead was calculated using Equation 2.2 for all three
electromagnets selected. The hydrodynamic drag force on the SCP beads was calculated for
various flow rates using Equation 2.3. The hydrodynamic drag force for flow rates in the range
of 1-10 μL/min and magnetic force exerted by three electromagnets is shown in Figure 5.26.

Figure 5.26 Comparison of magnetic field strengths of electromagnets with drag force
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It can be seen from Figure 6.18 that EM1 and EM3 can generate a magnetic force of 0.76 pN and
0.73 pN which are not sufficient to overcome the hydrodynamic drag force of 1.4 pN at a flow
rate of 1 μL/min. EM2 can generate a magnetic force of 2.6 pN which is enough to overcome the
hydrodynamic drag force up to 1.5 μL/min. In case of EM2 which could be used up to 1.5
μL/min, it was not possible to obtain repeatable results as the top surface of the electromagnet
was not perfectly flat and it wasn’t possible to make a uniform contact with the bottom surface of
the microfluidic system. The setup required a mini lab jack to raise the electromagnet and bring
it in contact with the device under test and was also very sensitive to any movements of the
device while in operation. The large diameters of the electromagnet would also require the
microfluidic connectors to be placed wider apart to provide enough space to position the
electromagnets in contact with the mixing chamber of the device. The electromagnets tested had
insufficient magnetic field strengths and even when successful at very flow rates could not
provide repeatable results. Due to these limitations and disadvantages, the electromagnet
approach to capture SCP beads was not suitable.
5.6.2 Permanent Magnets
Three permanent magnets of various size and strengths, namely PM1, PM2 and PM3 were
tested. In case of permanent magnet PM3, it was possible to capture the SCP beads up to a
sample flow rate of 1.5 μL/min. In case of permanent magnets PM1 and PM2, it was possible to
capture the SCP beads up to 10 μL/min. The hydrodynamic drag force and magnetic force
exerted by the permanent magnets was calculated using Equation 3.1 and Equation 3.2
respectively. Figure 5.27 shows that PM3 can generate a magnetic force of 2.05 pN which can
overcome the hydrodynamic drag force up to a flow rate of 1.5 μL/min only. PM1 and PM2 can
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generate a magnetic force of 16.5 pN and 24.0 pN

respectively and can overcome the

hydrodynamic drag forces up to 10 μL/min.

Figure 5.27 Comparison of magnetic field strengths of permanent magnets with drag force
Figure 5.28 (a) shows a top view of an empty mixing chamber of a microfluidic channel with a
permanent magnet placed below it and before a bead sample was injected into the device. Figure
shows the empty mixing chamber and mixing chamber with the trapped beads after the SCP
beads were injected into the device at a flow rate of 10 μL/min. The periphery of the circular
mixing chamber can be seen and the group of trapped SCP beads appears with an orange shade
in the Figure 5.28 (b). Based on these results, permanent magnet PM1 was selected for all
magnetic separations within the microfluidic channel as the magnetic flux density was high
enough to capture moving beads up to a flow rate of 10 μL/min. Also, the small size of PM1
with a diameter of 4.8 mm and a thickness of 3.2 mm makes it compact and easier to integrate
with the microfluidic device without interfering with the fluidic connectors.
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Figure 5.28 Images of the mixing chamber with a permanent magnet in the background (a)
Before the beads were injected into the circular mixing chamber (b) after beads were injected
with trapped beads (appears orange in color) inside the mixing chamber

5.7

Integrated Microfluidic System Testing

Two different testing protocols were employed to evaluate the performance of the integrated
microfluidic system. In the first test, the integrated microfluidic system was used for detection of
biotin coated microbeads. In the second test, the integrated microfluidic system was used for
immune based microbead insulin detection.
5.7.1 Impedance Detection of BCF Microbeads
Impedance spectrum results are commonly represented in a Bode plot format, where the
magnitude of the impedance (log scale) is plotted on the y-axis and frequency on the x-axis (log
scale). Figure 5.29 shows the impedance spectrum (Bode plot representation) for all
concentrations of BCF beads ranging from 1.9

105 to 4.8

106. The magnitude of impedance

increased with increase in the number of BCF beads. In order to determine the frequency at
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which the maximum change in absolute impedance between the BCF beads and the control was
obtained, a curve was drawn between normalized impedance change (NIC) and frequency. NIC
was defined by the following equation:
(5.11)

where

is the absolute impedance of the control and

is the absolute impedance

of the sample containing BCF beads.

Figure 5.29 Impedance spectrum (Bode plot) for different concentrations of BCF beads
As shown in Figure 5.30, the impedance change (represented by NIC) showed an increase from
5% to 63% in the frequency range from 1 kHz to 80 kHz, remained constant at 63% in the
frequency range from 80 kHz to 1 MHz, and then decreased from 63% to 3% at higher
frequencies. A mid-frequency value of 200 kHz where a peak NIC was observed was selected to
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compare the impedance changes for all concentrations of BCF beads. The magnitude of
impedance measured (three replicates) at 200 kHz for different concentrations of BCF beads
from 1.9×105 beads to 4.8 × 106 beads is shown in Figure 5.31. It can be observed that there is no
significant difference in impedance between control (SCP beads) and concentrations 1.9 × 105
and 4.8 x 105 microbeads.

The difference in impedance with respect to control for a

concentration of 1.9 × 105 microbeads and 4.8 × 105 microbeads was 3% and 7% respectively.

Figure 5.30 The difference in magnitude of impedance (represented by NIC) between 4.8 106
BCF beads and control sample. NIC was calculated for the measurements in the range of
frequency from 1 KHz to 10 MHz.
The difference in impedance with respect to control for concentrations 9.6 × 105 microbeads, 1.9
× 106 and 1.9 × 106 microbeads was observed to increase linearly and was 16%, 32% and 63%
respectively. There is no detectable and repeatable change in impedance between 4.8 x 105 and
9.6 x 105. The lower detection limit for BCF microbeads is 1.9 x 106 microbeads. The
experimental data of an impedance biosensor for the detection of BCF beads attached to SCP
beads is represented by an equivalent circuit as shown in Figure 5.32 [179-180]. The equivalent
circuit consists of two double layer capacitors (CPE), one for each set of the electrodes,
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resistance of medium (Rs), and a stray capacitance (Cs) connected in parallel. Constant phase
element (CPE) is used to model the double layer capacitance of the electrodes.

Figure 5.31 Magnitude of impedance at 200 kHz for various concentrations of BCF beads
This is commonly favored over the use of a simple capacitor [181]. CPE accouns for the effect of
ionic species on the capacitance near the surface of an electrode. Rs accounts for change in
conductivity and charge transport across the bulk medium. Cs represents the stray capacitance of
the impedance measurement system associated with electrodes, shielding, wiring and connecting
cables and chrome adhesion layer between gold and glass. The total impedance of the equivalent
circuit can be expressed by the following equations:

CPE

Rs

CPE

Cs
Figure 5.32 Equivalent circuit for impedance measurement system
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where Z1 and Z2 are the impedance of the two branches of the equivalent circuit containing (CPE
Rs

CPE) and Cs respectively. Zview software (Scribner Associates Inc., Southern Pines, NC)

was used to fit the experimental impedance data to the chosen equivalent circuit model. The
fitting was performed by the software using complex non-linear least-square method. Figure 5.33
shows the bode plot of the experimental and fitted data from Zview software based on equivalent
circuit.
There are three distinct regions in the impedance spectrum which correspond to the three types
of elements in the equivalent circuit. The double layer region is in the low frequency range from
10 Hz to approximately 30 kHz, where the double layer capacitance of the electrodes represented
by CPE dominates the impedance signal. For frequency ranging from 30 kHz to 1 MHz,
conductivity of the medium is the key factor and the bulk medium resistance determines the
signal. At a frequency greater than 1MHz is the dielectric region where the signal is dominated
by the stray capacitance of the system.
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(a)

(b)

Figure 5.33 Bode plots of the impedance spectra of experimental and curve fitted data of control
in the frequency range 10 Hz to 10 Mhz. Solid lines indicate the experimental data and crosses
indicate the fitted data obtained from Zview software based on the the equivalent circuit. (a)
Magnitude of impedance (b) Phase angle in degrees
The division of the impedance spectrum into three distinct regions can be further analyzed with
the help of the phase angle spectrum shown in Figure 5.33 (b). An electrical current passing
through a capacitor is phase shifted by −90° with respect to the applied voltage. The phase angle
in a capacitance dominated region of the impedance spectrum is therefore close to −90°. The
current passing through a resistor is always in phase with the applied voltage. Therefore the
phase angle in resistance dominated region of the impedance spectrum is close to 0°. As shown
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in Figure 5.33 (b), the phase angle is close to −90° on both ends of the impedance spectrum, and
close to 0° in the middle. It can thus be concluded that both the low and high frequency spectra
are dominated by a capacitance while the mid frequency region by a resistance. The simulated
values of Rs, CPE and Cs in the equivalent circuit for control sample and sample with 4.86 × 106
BCF microbeads are listed in Table 5.3. These values were obtained by curve fitting the
respective experimental impedance data to the equivalent circuit.
Sample
Control
4.86 × 106 BCF beads
Change (%)

RS (kΩ)
3.56
5.47
53.65

CPE (nF)
15.33
16.36
6.72

CS(pF)
13.70
13.60
0.73

Table 5.3 Simulated values of Rs, CPE and Cs in the equivalent circuit for control sample and
sample with 4.86 × 106 BCF microbeads and their respective percentage changes with respect to
control

The presence of BCF microbeads increased the value of the bulk medium resistance by 53.65%
when compared to the control sample. The presence of BCF microbeads increased the value of
CPE by 6.72% when compared to the control sample. The value of Cs did not change
significantly since the connecting wires, electrode chip and all other parameters in the system
remained constant. The change in impedance due to the presence of BCF microbeads was
dominated by change in the bulk medium resistance when compared to change in values of
double layer capacitance and stray capacitance.
5.7.2 Immuno Microbead Based Insulin Detection
The procedure for determining the coupling efficiency of MAI-Ab and magnetic microbeads has
been described in Chapter 3 under “Coupling efficiency determination”. The fluorescence values
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measured for the provided BSA standards in the Quant-iT protein assay kit is shown in Figure
5.34.

Figure 5.34 RFU vs concentration of BSA standards

Each data point is an average of three readings obtained by fluorescence measurements of three
samples of each BSA standard. A standard curve was obtained by fitting a straight line to the
data points. The coupling efficiency CE was calculated to be 85% using the following equation
(

) (
(

)
)

(5.15)

The impedance spectrum (Bode plot representation) for all concentrations of insulin ranging
from 10-10M to 10-5M is shown in Figure 5.35. The magnitude of impedance increased with an
increase in the concentration of insulin.
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Figure 5.35 Impedance spectrum (Bode plot) for different concentrations of insulin
As shown in Figure 5.36, the impedance change (represented by NIC) showed an increase from
3% to 32% in the frequency range from 1 kHz to 28 kHz, remained constant at 32% in the
frequency range from 28 kHz to 1 MHz, and then decreased from 32% to 1% at higher
frequencies. A mid-frequency value of 100 kHz where a peak NIC was observed was selected to
compare the impedance changes for all concentrations of insulin with respect to control. The
magnitude of impedance measured at 100 kHz for different concentrations of insulin from 10 10

M to 10-5M insulin is shown in Figure 5.37
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Figure 5.36 The difference in magnitude of impedance (represented by NIC) between 10-5M
insulin sample and control sample. NIC was calculated for the measurements in the range of
frequency from 1 KHz to 10 MHz.

Figure 5.37 Magnitude of impedance at 100 kHz for various concentrations of insulin

Figure 5.38 shows the experimental and fitted data simulated from Zview software based on
equivalent circuit. The simulated values of Rs, CPE and Cs in the equivalent circuit for control
sample and sample with insulin concentration of 10-5M are listed in Table 5.4. These values were
obtained by curve fitting the respective experimental impedance data to the equivalent circuit.
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(a)

(b)

Figure 5.38 Bode plots of the impedance spectra of experimental and curve fitted data of control
in the frequency range 10 Hz to 10 Mhz. Solid lines indicate the experimental data and crosses
indicate the fitted data obtained from Zview software based on the equivalent circuit. (a)
Magnitude of impedance (b) Phase angle in degrees

Sample
Control
10-5 M insulin
Change (%)

RS (kΩ)
5.23
6.73
28.68

CPE (nF)
14.46
16.19
11.96

CS(pF)
13.50
13.70
1.48

Table 5.4 Simulated values of Rs, CPE and Cs in the equivalent circuit for control sample and
sample with 10-5M insulin and their respective percentage changes with respect to control.
The presence of insulin increased the value of the bulk medium resistance by 28% when
compared to the control sample. The presence of insulin increased the value of CPE by 12%
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when compared to the control sample. The value of Cs did not change significantly (1.5%) since
the connecting wires, electrode chip and all other parameters in the system remained constant.
The change in net impedance due to the presence of insulin was dominated by change in the bulk
medium resistance when compared to change in values of double layer capacitance and stray
capacitance.
It can be observed from Figure 5.37 that there is no detectable difference in impedance between
control and the lower insulin concentrations of 10-10M and 10-9M. The difference in average
impedance with respect to control for 10-10M and 10-9M is only 0.8% and 1 % respectively. In
case of insulin concentrations 10-8M, 10-7M and 10-5M there is a detectable difference with
respect to control. The difference in average impedance with respect to control for insulin
concentrations 10-8M , 10-7M and 10-5M was observed to increase linearly and was 10%, 19%
and 32% respectively. The variation in impedance with respect to the average value for 10 -8M,
10-7M and 10-5M is 10%, 7% and 7% respectively. There is not a detectable difference in
impedance between concentrations of 10-8M and 10-7M when taking the variation with respect to
the average impedance value into consideration. The lower detection limit is 10-5M with a 32%
increase in the average impedance with respect to control. The total detection time was 20
minutes.
A multiwalled carbon nanotube/dihydropan (MWCNT/DHP) composite sensor for the
electrochemical detection of insulin in a microphysiometer device has been reported [182]. This
device has been reported to have a detection limit of 10-6M insulin, compared to the 10-5M
detection limit achieved with the microfluidic system in this study. The microphysiometer device
is more suitable for laboratory testing when compared to the fully integrated microfluidic system
in the present study that can be used for point-of-care testing. The microphysiometer electrodes
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had to be conditioned for 1 hour before any insulin testing. Also, the resistance of
MWCNT/DHP film to shear force under flow conditions has been reported [182] to be a
concern. The microelectode used for impedance detection in this study does not require any
conditioning and the stability of the electrodes under flow conditions was good.
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6. CONCLUSIONS
The performance testing of the three micropump designs were successfully completed. The
performance tests were performed to determine the flow rate variation with respect to actuation
frequency and actuation pressure. The performance testing results indicated that the flow rate
increased with frequency until a peak flow rate was observed at an optimum frequency. The flow
rate dropped for frequencies higher than optimum frequencies. At frequencies below the
optimum frequency, the flow rate increased with increasing pressure. The repeatability of flow
rates within a micropump and also between multiple micropumps of each design was
experimentally determined. The highest flow rate was observed in Design3 micropumps, with a
peak flow rate of 16 µl/min at 30 psi, 20 Hz operating condition. The mean variation in flow rate
for a micropump of Design3 was 1.9%, with a maximum variation of 5.4% and a minimum
variation of 0.8%. The fabrication yield with Design 3 was also observed to be higher than other
designs. Based on the performance test results, Design3 was selected for the fully integrated
microfluidic system. In order to better explain the results of the micropump performance and to
validate the trend of flow rate variation with actuation frequency, an equivalent circuit simulation
and COMSOL simulation was carried out. The simulation and experimental results showed a
consistent trend for flow rate variation with respect to frequency and the peak flow rate at an
optimum frequency.
The performance testing of three micromixer designs were successfully completed. Both
qualitative and quantitative tests were performed. A qualitative testing based on mixing colored
dyes indicated that the active mixing using a micromixer shortened the mixing time by 18 times
when compared to mixing based on diffusion alone. The quantitative tests were performed to
determine the mixing performance based on streptavidin-biotin conjugation reaction with respect
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to flow rate and actuation frequency. The performance testing results indicated that the mixing
efficiency increased with frequency until a peak mixing efficiency was observed at an optimum
frequency. The mixing efficiency dropped for frequencies higher than optimum frequencies. The
mixing efficiency was also observed to depend on the sample flow rates. The optimum flow rate
for mixing efficiency was experimentally determined. The highest mixing efficiency was
observed in Design3 micromixer, with an 85% mixing efficiency at an operating condition of 2
µL/min, 10 Hz and 20 psi. Based on the performance test results, Design3 micromixer was
selected for the fully integrated microfluidic system.

A micropump (Design3) and micromixer (Design3) were integrated on a single device to obtain
an integrated micromixer-micropump and tested for mixing efficiency based on streptavidin
biotin conjugation reaction. Based on the performance testing results, the optimum operating
conditions for obtaining the highest mixing performance was determined to be 2 µL/min sample
flow rate, 10 Hz actuation frequency and a compressed air pressure of 20 psi. The micromixer
was operated under these conditions for all further testing in the fully integrated microfluidic
system.
The testing for magnetic microbead separation included both electromagnets and permanent
magnets of various sizes and magnetic strengths.

Three permanent magnets and three

electromagnets of different size and strength were tested for their suitability in magnetic
separation of SCP microbeads flowing within a microfluidic system. It was experimentally
determined that the magnetic field strength generated electromagnets was not sufficient enough
to overcome the hydrodynamic drag force for flow rates in the range 1 – 10 µL/min. The test
results with permanent magnet indicated that permanent magnet PM1 was suitable in separating
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moving microbeads up to a flow rate of 10 μL/min. Also, the compact size of makes it easier to
integrate within the microfluidic system without interfering with the microfluidic connectors.
Multiple designs of IDE were successfully developed and tested for impedance spectrum
measurements. A labVIEW plug and play instrument driver for HP4192A was downloaded from
National Instruments website and modified to perform a log sweep. An impedance analyzer
coupled with the labVIEW program was used to record the impedance spectrum measurements
in a microfluidic system.
A fully integrated microfluidic system with a micropump, micromixer and IDE was successfully
developed for detection of biomolecules. The fully integrated microfluidic system was used to
detect target BCF microbeads and insulin. The detection of BCF microbeads was based on
streptavidin-conjugation reactions between SCP microbeads and target BCF microbeads.
Impedance spectrum measurements were made for concentrations of BCF microbeads ranging
from 1.9

105 to 4.8

106 microbeads. The lower detection limit for BCF microbeads was

experimentally determined to be 1.9 x 106 microbeads. The insulin detection was based on
mixing MBAC with target insulin molecules to allow binding reaction between target insulin
molecules and MAI-Ab, and followed by impedance spectrum measurements. Impedance
spectrum mere made for insulin concentrations ranging from 10-10M to 10-5M. The lower
detection limit for insulin detection was determined to be 10-5M. The total detection time was 20
minutes. An equivalent circuit analysis was performed to explain the impedance spectrum
results.
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7. FUTURE WORK
Based on the results of the present study, some of the future work possibilities are discussed in
the sections below.
7.1

Parallel Processing

The fully integrated microfluidic system can be expanded to enable parallel processing of
different insulin concentration samples simultaneously. Also, multiple testing of a single insulin
sample can be performed simultaneously to confirm the reliability of the results.
7.2

Inclusion of Valves

In the present study, a continuous flow microfluidic system was developed without any control
valves. The inclusion of valves will be necessary for expanding the current design to perform
parallel processing and will also provide better process control. For example, inclusion of valves
in the micromixer mixing chamber would enable a closed system mixing and control over the
residence time of the mixing species within the mixing chamber.
7.3

Nanobeads

The replacement of microbeads with nanobeads can make the reaction kinetics faster and
improve the capture efficiency. The high surface to volume ratio of nanobeads can reduce the
quantity of bead sample required. However, the magnetic separation of nanobeads would require
higher magnetic field strength when compared to microbeads.
7.4

COMSOL simulation

A 3D COMSOL model can be implemented instead of the 2D model used in this study. Also, the
model can be updated to include the effects of air bubbles within the microfluidic system and the
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effects of pressure drop caused by the microfluidic connectors and external tubing on the
microfluidic system. Also, COMSOL can be used for simulation of impedance change.
7.5

PDMS Alignment System

All the alignments between different layers of PDMS in the present study were performed by
manual alignment with tweezers under a stereo microscope. The development of a rapid and
reproducible PDMS layer aligning and bonding system would improve the yield of fabrication.
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